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ABSTRACT 
 
The discovery of cell free foetal DNA (cffDNA) in 1997 allows for the combination of 
accuracy as well as non-invasiveness for prenatal diagnosis. This non-invasive genetic test 
requires only a maternal blood sample from which the cffDNA can be isolated and analysed. 
In this work cffDNA was isolated from a maternal blood sample using a micro-fluidic device 
which was fabricated using hot embossing and laser ablation techniques. The DNA sample 
was first pre-concentration by electrokinetic trapping (EKT) and then isotachophoresis (ITP). 
The concentrated sample was then separated by size using capillary electrophoresis (CE), all 
in a single device. All parameters and processes concerned with the micro-fluidic device were 
optimised sequentially. These parameters include both the chemical components as well as 
the physical processes which occur. The DNA used for the optimisation protocol was 
analysed using fluorescence spectroscopy, agarose gel electrophoresis as well as an Agilent 
Bioanalyser. The optimised protocol included a 9% acrylamide/pDMA matrix, 3 M N,N-
dimethylurea as a denaturing agent, with tris based buffers for pre-concentration steps and 1X 
TBE (tris/borate/EDTA) buffer for capillary electrophoresis. The applied voltage of ITP was 
300 V and CE was carried out at 180 V. The timing at which DNA was extracted from the 
device was kept at time = 60 s intervals. The optimised protocol was then used for real 
sample analysis and these samples were obtained from mothers pregnant with male foetuses. 
The DNA extracted from the micro-fluidic device was then analysed using real time PCR 
(RT-PCR) in order to distinguish which was maternal and which was foetal. This was carried 
out by amplification of male and general (present in male and female) genes respectively. 
RT-PCR results confirmed that only the male specific gene was amplified in initial samples 
exiting the device and it was thus successful in isolating cffDNA from a maternal plasma 
sample.   
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
1.1. Background 
 
Microfabrication is an upcoming technique with applications in various fields of research. It 
has been found particularly useful lately in the field of science and medicine. The reason for 
this trend is the push towards quicker and easier technology for the early diagnosis and 
treatment of disease. Miniaturisation is the key towards achieving this technology using 
advances in microfabrication. Fabrication on this small scale can be achieved using 
techniques such as etching, lithography [1], embossing, bonding [2], thin film deposition, 
doping [3] and polishing. Microfabrication found most of its uses in micro-electronics by 
using a semiconductor, such as silicon, as a substrate [4]. This type of microfabrication is 
mostly used to produce electrical components, such as integrated circuits, by fabricating 
smaller and smaller transistors. A “prediction” of miniaturisation was made my Gordon 
Moore in 1965, when he stated that the number of transistors on integrated circuits would 
double every two years [5]. In essence this means that these circuits could half in size in the 
allotted time. 
 
However, silicon is not optimal for application in the scientific or medical field and thus 
plastics have currently been used. Substrates such as PMMA (polymethyl methacrylate) [6], 
PDMS (polydimethylsiloxane) [7], and PC (polycarbonate) [8] plastics are quite common for 
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biological applications. This is due to the low cost of plastics as well as the fact that they are 
easy to handle and manipulate using simple techniques. These characteristics make it possible 
for mass production of plastic micro-fabricated devices and thus the added benefit of 
disposability. Disposable devices minimise issues such as clogging, sterilisation and drift and 
are popular in a large number of commercial enterprises already [9]. 
 
Using tools provided by advances in microfabrication, on cheap substrates such as plastics, it 
is possible to produce devices that are small, portable and easy to use for point of care 
diagnostics. One of the common applications is the development of microfluidic devices for 
DNA analysis and sequencing. This is done by incorporating capillary columns for DNA 
electrophoresis, into a micro-fluidic system. The development of devices such as these is 
important for patients who cannot afford expensive tests and experiments carried out at 
hospitals and laboratories. This makes it possible for them to obtain results in a matter of 
minutes instead of hours or even days. The speed and efficiency of micro-fluidic devices also 
allow for the miniaturisation of what is routinely large and bulky equipment.  
 
DNA sequencing is the process of reading a sequence of nucleotide bases which make up the 
genome. The first method of DNA sequencing is known as the Sanger method and is based on 
electrophoresis, which separates DNA strands according to size. Gel electrophoresis involves 
the migration of DNA fragments through a matrix by applying a potential between two 
oppositely charged electrodes, thereby causing size separation of the DNA. Gel 
electrophoresis usually occurs in a slab of agarose or acrylamide gel, but another method 
exists which is known as capillary electrophoresis. In this case DNA separation occurs in a 
thin capillary column instead of a slab of gel. Instruments that carry out conventional 
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capillary electrophoresis are big and usually consist of long and big capillary columns. By 
taking advantage of microfabrication of plastics, it is now possible to incorporate capillary 
columns into tiny micro-fluidic devices for DNA separation.  
 
The miniaturisation of this new technology has various parameters which require 
optimisation. Especially if more processes are incorporated into a single device i.e. for the 
pre-concentration of a DNA sample. In the current work the optimisation of such a device is 
carried out. Pre-concentration of DNA can be carried out using various techniques in 
integrated devices such as sweeping techniques [10], solid phase extraction technology [11], 
field amplified stacking [12], electrokinetic trapping [13] and isotachophoresis [14]. The pre-
concentration in this case is carried out by two subsequent methods i.e. electrokinetic trapping 
and isotachophoresis. The concentrated DNA sample can then be separated by size using 
capillary electrophoresis.  
 
These three processes are carried out on a DNA sample inserted into the microfluidic device. 
First the DNA is pre-concentrated to minimise sample size and then separated according to 
DNA fragment length by capillary electrophoresis. New micro-fabricated devices have to be 
reliable and reproducible before its application to real samples. Parameters to be optimised 
include physical as well as chemical variables, in order to produce a device that can be used to 
separate DNA efficiently, quickly and with high precision in real DNA samples. The 
application of such micro-fluidic devices can be described in section 1.2.   
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1.2. Problem Identification 
 
DNA analysis is one of the key diagnostic tools for genetic testing these days. Thus there is 
always a driving force towards achieving better and simpler methods of analysing DNA. 
Genetic diseases such as sickle cell anaemia, Down syndrome, coeliac disease and cystic 
fibrosis all have serious side effects which require early diagnosis and treatment. Recognition 
of these diseases early on allow for much better disease management as well as mental 
preparation. Genetic diseases not only affect adults but also unborn babies. Current methods 
of carrying out prenatal genetic tests are mostly invasive and might even result in miscarriage. 
These methods include amniocentesis, cordocentesis [15], chorionic villus sampling and even 
ultrasounds [16], which give very little information about any genetic abnormalities. Thus it is 
very important to develop prenatal tests which are non-invasive to both the baby and mother, 
and at the same time give sufficient information about the foetus.  
 
o This was made possible in 1997 when the existence of cell free foetal DNA was 
discovered in maternal blood [17]. These are short fragments of DNA that belong to 
the foetus, but are circulating in the blood stream of the pregnant mother during 
gestation. These fragments of DNA are characteristically short in length and can thus 
be separated from maternal DNA according to size. The only sample one would need 
is a tiny amount of maternal blood from which both the foetal and maternal DNA can 
be extracted and tested. The cell free foetal DNA can hereby be isolated from the other 
DNA via size separation and taken for further genetic testing. This allows for prenatal 
diagnostic tests to be carried out without any stress to mother and child.  
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Pregnancy related complications such as pre-eclampsia results in a higher concentration of 
cell free foetal DNA circulating in the mother’s blood. Theoretically, the level of cell free 
foetal DNA can be monitored as an indication of this disease. Pre-eclampsia is a disease that 
results in high blood pressure, oedema, and sudden weight gain as well as many other 
symptoms [18]. This disease can be very dangerous to the health of the mother and currently, 
diagnosis of this disease can only be carried out at either the hospital or a doctor’s office. The 
isolation and quantification of cell free foetal DNA can thereby be a key tool for the diagnosis 
of pre-eclampsia as well.  
 
Taking advantage of the fact that cell free foetal DNA exists in fragments less than 300 bp 
and maternal more than 500 bp, it is possible to use a micro-fluidic device described 
previously in order to isolate cffDNA from a maternal plasma sample. This size separation 
can be carried out by using capillary electrophoresis. The cffDNA can then be sequenced in 
order to obtain genetic information, but it can also be distinguished from maternal DNA with 
real time PCR. The RT-PCR protocol can be adjusted to detect, amplify and quantify foetal 
and maternal genes respectively to differentiate between cffDNA and maternal DNA.  
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1.3. Objectives 
 
In order to develop a micro-fluidic device which is easy, cheap, simple and requires a 
minimal sample to analyse, many components have to be considered. This microfluidic device 
will essentially be used for the size separation of cell free foetal DNA from a real maternal 
plasma sample. Thus the following objectives for this work have been derived: 
 To optimise chemical components of the micro-fluidic device including: 
o The buffers used within the micro-fluidic device 
o The sieving matrix in which DNA will separate according to size 
o The denaturing agent within the sieving matrix that increases resolution and 
separation of DNA fragments 
 
 To optimise physical processes occurring within the microfluidic device 
o The voltage of electrokinetic trapping, isotachophoresis and capillary 
electrophoresis 
o The timing at which DNA is extracted from the micro-fluidic device for 
analysis 
o The temperature of capillary electrophoresis 
o The length of the capillary column 
 
 To use the optimised micro-fluidic device and processes to separate cell free foetal 
DNA from maternal plasma samples 
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1.4. Research Framework 
 
This research work followed a specific route in which various components have been 
optimised. Initially, the micro-fluidic device or chip was cleaned and prepared for the 
experiment. The optimisation of the experimental protocol can be separated into two different 
fields but were carried out as individual steps. These two fields are the chemical optimisation 
and the physical optimisation of the process. The chemical components optimised include the 
composition of the sieving matrix within the capillary column, the denaturing agent present in 
the column as well as the buffer system which exists in the chip. The physical processes to be 
optimised include the respective voltage of each step in the micro-fluidic device, the 
temperature of DNA separation, the timing of the overall process as well as the length of the 
capillary column. The optimised process will then be applied for the separation of cell free 
foetal DNA from a real maternal sample. The research framework can be represented by 
scheme 1: 
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Scheme 1: Research Framework  
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1.5. Outline of thesis 
 
This thesis is divided into 7 chapters which will all be described briefly below: 
Chapter 1 is the introduction which gives a brief background into the basic methods of micro-
fabrication. The use of micro-fabrication to produce devices such as micro-fluidic chips, 
which are widely used in DNA sequencing and analysis, is discussed. It compares previous 
methods of prenatal diagnosis to the discovery of cell free foetal DNA in maternal plasma. 
This chapter also states the objectives of the work and also a framework of how the 
experimental process occurred.  
 
Chapter 2 is a literature review relating to current methods of carrying out prenatal diagnosis 
and the difficulties associated with them. It discusses recent advances in prenatal diagnosis 
since the discovery of cell free foetal DNA. Methods of fabricating micro-fluidic devices are 
also briefly described. Furthermore the processes of pre-concentrating DNA such as 
electrokinetic trapping and isotachophoresis were reviewed. Capillary electrophoresis, which 
is the new way of sequencing and separating DNA according to size, has also been studied. 
Recent advances in lab on a chip technology are also discussed in this chapter.  
 
Chapter 3 is the section concerning the techniques used in this work and is described in detail 
here. These techniques include hot embossing, laser microfabrication, electrokinetic trapping, 
isotachophoresis, agarose gel electrophoresis, capillary electrophoresis, fluorescence 
spectroscopy and real time PCR. 
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Chapter 4 contains a list of all the materials and instruments used, which is the first section 
explaining the experimental procedures. The protocols for assembling devices as well as the 
experiments carried out on DNA by these devices. The optimisation steps in the protocol are 
listed here as well as a basic statement about what these steps entail.  
 
Chapter 5 goes into more detail about each optimisation step and what the result of each step 
entails. It also describes how the optimised protocol is applied to real samples as well as the 
real time PCR protocol used. 
 
Chapter 6 contains all results concerning the optimisation process which are discussed in this 
chapter. Here, the result of this devices application to real samples is described. 
 
Chapter 7 contains the conclusion of the entire work and recommendations for its future use 
are described here. 
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CHAPTER 2 
 
2.0. LITERATURE REVIEW 
 
2.1. Prenatal Diagnosis 
 
Prenatal diagnosis is a key factor when carrying an unborn child, not only to monitor the baby 
but also for early detection of possible diseases or abnormalities. This is important to allow 
the mother the choice of treatment or to mentally prepare herself for the arrival of her baby. 
Various methods used for prenatal diagnosis are discussed below. 
 
2.1.1 Non-invasive methods 
 
Currently, there are a number of options when it comes to prenatal diagnosis. One of the most 
common methods of non-invasive monitoring of a foetus is the use of ultrasounds [19]. 
Ultrasounds date back to the early 19
th
 century and have been a key tool for the detection and 
monitoring of congenital diseases. Diseases concerning the digestive system such as the 
gastrointestinal tract have been found to be detectable using ultrasounds [20]. This allows for 
management of these diseases in adults as well as being capable of monitoring foetuses. 
Congenital diseases such as cystic fibrosis [21], cleft palate [22] and even Down syndrome 
[16] have been detected using various forms of sonography. In one instance of cleft palate 
detection, a 3D mode of ultrasounds was used in which different planes are reconstructed to 
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form a multi-dimensional image. In another case of Down syndrome detection a nuchal 
translucency scan was done in order to monitor the thickness of the nuchal fold (neck). The 
presence of this increased nuchal thickness was found as an indication of Down syndrome in 
1985 [23]. Another option of obtaining scanned images of a foetus is the use of foetal MRI 
(magnetic resonance imaging) which gives a higher resolution image of the internal organs of 
the foetus [24]. This method has been proven to detect and aid in the management of 
abdominal diseases in foetuses.  
 
2.1.2 Invasive methods 
 
Other forms of prenatal diagnosis are considerably more invasive than the scans described 
above. In the case of genetic testing, a well-known method of prenatal diagnosis is 
amniocentesis. This method entails the insertion of a needle into the amniotic sac and the 
withdrawal of amniotic fluid which undergoes testing for the detection of various diseases. 
However, the method is not only painful but has been found to lead to both foetal and 
maternal complications. Amniocentesis has previously been associated with miscarriages 
[15], amniotic band syndrome [25] and intra-amniotic infection which are possible risks of 
this technique.  
 
An alternative to amniocentesis is chorionic villus sampling. In this technique instead of 
amniotic fluid being withdrawn, a sample of the chorionic villi is extracted i.e. placental 
tissue. Studies have shown that this technique has an even higher pain sensation than 
amniocentesis [26]. However, it has also been proven to give more reliable data as well as 
  
 
 
13 
 
allowing for rapid karyotyping, biochemical and genetic studies in early pregnancy compared 
to amniocentesis [27].  
 
Along with the techniques listed above, there are other methods of prenatal diagnosis such as 
percutaneous umbilical blood sampling (PUBS), which involves the extraction and analysis of 
umbilical cord blood. A needle is inserted into the umbilical cord with the guidance of an 
ultrasound. The danger of this test however grows with the amount of punctures the umbilical 
cord undergoes. Foetal and neonatal deaths can be as high as 5% after this procedure [28]. 
Another invasive prenatal diagnostic test exists although it is not as commonly used. This test 
is known as an embryoscopy or foetoscopy. This technique can be used as both a diagnostic 
tool as well as a treatment option. It entails a small incision being made in the abdomen to 
allow an endoscope access to the amniotic sac, the foetus, umbilical cord and foetal side of 
the placenta. An endoscope inserted through the abdomen and uterus has previously been 
used to monitor abnormalities in membrane rupture and was proven successful [29]. This 
technique can also be used to treat birth defects such as tumours in vivo. A foetoscopic 
surgery was carried out in utero and was successful in removing all traces of an oral teratoma 
in an unborn baby [30]. However, in order to minimise the invasiveness of a test and maintain 
the high level of genetic and biochemical information obtained from it, a new method of 
prenatal diagnosis is needed.  
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2.2. Cell free foetal DNA 
 
The discovery of cell free foetal DNA in 1997 revolutionised prenatal diagnosis [17]. This 
type of DNA exists as tiny fragments of DNA that belong to the foetus, but are circulating in 
the blood system of the mother from around 4 weeks gestation [31]. Although the exact 
source of the DNA was not previously known, it was suggested that they came from the 
connection which exists between mother and child through the umbilical cord [32]. However, 
more recently it has been proven that they emanate from trophoblast cells present in the 
placenta [33]. Analysis on cffDNA has shown that the whole foetal genome is present in 
maternal plasma [34], making it possible to monitor any kind of genetic disease that the foetus 
might have, from a sample of maternal blood. 
 
2.2.1. Applications of cell free foetal DNA 
 
Since its discovery it has found a wide application in prenatal diagnosis. These include sex 
determination [35], in which one group used quantitative fluorescent polymerase chain 
reaction (QF-PCR) to analyse cffDNA in first trimester maternal plasma. They were found to 
successfully determine the gender of the foetus using this method. In another study, 
quantitative PCR was used to determine the sex of a foetus from a maternal blood sample by 
amplification of the SRY gene. This gene is male specific and would thus only be amplified 
or have a positive signal in male foetuses. The protocol was found to have 97.2% sensitivity 
and 100% specificity [36] in this case. The results obtained from the groups study is shown in 
table 1 below:  
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Table 1: cffDNA results (Rijnders, R et al.) 
SRY Real-Time Quantitative Polymerase Chain Reaction Results Obtained With Maternal 
Plasma in Comparison With Sex After Birth and/or Sex as Determined by Ultrasound. 
Foetal 
sex 
21 Samples with 1 DNA isolation, number of 
positive replicates (interpretation of test 
results) 
44 Samples with 2 DNA isolations, number of 
positive replicates (interpretation of test 
results) 
0/3 
(negative) 
1/3 
(negative) 
2/3 
(positive) 
3/3 
(positive) 
0/4 
(negative) 
1/4 
(negative) 
3/4 
(positive) 
4/4 
(positive) 
Female 
(n =29) 
Male 
(n =36) 
10 1 7† 3 17* 1 7 19 
For the first 21 cases, 1 DNA isolation was tested (in triplicate), and for the subsequent 44 
cases, 2 DNA isolations were tested (in duplicate). 
* In 1 case, only 3 replicates could be performed. 
† In 2 cases, only 2 of the 3 replicates could be performed. 
Table 2 above represents a study in which 65 blood samples were analysed in order to 
determine the sex of the foetus. The SRY real-time quantitative PCR test showed a negative 
result for all of the 29 female foetuses (results represented by bold print in table 2). In 35 of 
36 male foetuses, SRY was amplified in both DNA isolations which yielded a positive result. 
[36] 
 
Cell free foetal DNA has also been found to detect genetic disorders that contain an abnormal 
number of chromosomes, known as aneuploidies. A disorder in which one of the sex 
chromosomes are absent in women and only a partial chromosome is present in a single copy 
is known as Turner syndrome. This genetic disorder has great promise in being detected by 
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cell free foetal DNA analysis. A group has used DNA microarrays for the detection of Turner 
syndrome, another aneuploidy called trisomy21 (Down Syndrome) as well as SRY gene 
detection. This technique is known as comparative genomic hybridization (CGH) analysis 
[37]. In this case the group analysed cell free foetal DNA extracted from the amniotic fluid, 
now called AF cffDNA.  
 
Trisomy 21 or Down syndrome has been detected using cell free foetal DNA numerous times 
in research. This disease results in three copies of chromosome 21 instead of the normal two 
copies. Another example of prenatal diagnosis using cffDNA was that of Farina et al. [38]. 
This group isolated cffDNA from maternal serum samples at the second-trimester of 
pregnancy. A comparison was made between the levels of cffDNA in the second trimester of 
pregnancy with Down syndrome pregnancy compared to unaffected ones. Results showed that 
Down syndrome cases had a 1.7 times higher level of cffDNA than normal and that this type 
of analysis can increase the screening performance of the disease in second trimester.   
 
Single gene disorders are the results of a single gene mutation and cause various serious 
diseases such as Huntington’s disease, cystic fibrosis and also sickle cell disease. As we 
know, all these diseases have severe side effects which have a negative impact on the quality 
of life and are thereby important to diagnose prenatally. This has been proven possible by 
analysis of cell free foetal DNA by the Department of Genetics in Madrid, Spain. This group 
managed to non-invasively diagnose Huntington’s disease in foetuses whose fathers were 
affected, using cffDNA [39]. This group also used quantitative fluorescent polymerase chain 
reaction (QF-PCR) to detect this particular genetic disorder from a maternal plasma sample. 
Usually Huntington’s disease is diagnosed prenatally using chorionic villus sampling which 
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poses a 0.5%-1% risk of abortion. Gonzales-Gonzales et al. [40] has improved on methods of 
non-invasive diagnosis of this disease in foetuses. This group used cffDNA sequences of 
paternal origin to analyse and diagnose the disease, since the maternal DNA in plasma caused 
a large interference. Cell free foetal DNA has also been used to detect other gene disorders 
such as cystic fibrosis by the same group in 2002. Using a similar protocol as with 
Huntington’s disease, the group successfully detected the paternally inherited mutation at 13 
weeks gestation [41]. This analysis was carried out on cffDNA isolated from maternal plasma 
and serum samples.  
 
The uses and applications of cell free foetal DNA has successfully shown great promise as a 
non-invasive tool for prenatal diagnosis and has a definite future for commercialisation of 
these genetic tests. If it is possible to produce a device that is inexpensive, easy to use and 
portable, cffDNA can further revolutionise prenatal diagnosis. It is possible to take advantage 
of recent advances and the ease of microfabrication to possibly manufacture such devices for 
public use. 
 
2.3. Microfabrication 
 
Microfabrication found its origin in electronics, with silicon as a substrate. This semi-
conductor has been widely used for the development of electronic circuits. However, 
microfabrication has also found a large application in both biology and medicine. These 
applications are generally divided into four classes: tools for cell biology, tools for molecular 
biology, biochemistry and medical devices [9]. The application of analysing cffDNA would 
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ultimately fall into the category of becoming a medical device in the case of this work. 
Although not a device used for treatment, it would have diagnostic capabilities. The 
application of biological devices such as these has grown much more in the last decade, due 
to demands such as commercialisation of products, low volume consumption technologies 
and high throughput requirements. One of the substrates which have the capabilities of 
fulfilling these requirements is plastic. This is due to the fact that plastics are easily obtainable 
and very cheap; they are also easily manipulated into specific designs, as well as the fact that 
they can be mass produced easily. Various methods of micro-fabrication of plastics exist such 
as injection molding [42], casting [43], hot embossing and even laser ablation. The last two 
techniques mentioned will be reviewed in more detail since they were applied in this research 
work.  
 
2.3.1. Hot embossing 
 
Hot embossing is a common technique for the production of micro-devices using 
thermoplastics. This technique requires a mold or stamp from which it gets its structure and 
form. The most common stamp or mold used is made of polydimethylsiloxane (PDMS). The 
reason for its use is the elastic properties of PDMS as well as the low surface energy of the 
polymer, which makes it easier to demold after the hot embossing process. Goral et al 
successfully produced simple micro-fluidic devices using a PDMS mold and a polystyrene 
substrate [44]. The products in this case were micro-fluidic devices with large structures. The 
PDMS molds could be re-used in order to make further replicas of the device. 
 
  
 
 
19 
 
The process of hot embossing is shown in Figure 1 below. In a study by Becker et al., hot 
embossing procedure included the production of the embossing master by the LIGA method 
(LIGA is a German acronym for lithography, electroplating and molding – Lithographie, 
Galvanik, Abformung). The master was then used to emboss a pattern into a thermoplastic 
polymer i.e. either PMMA or PC. The master and substrate is placed onto the heating plates 
of the equipment. In the beginning of the procedure both are heated separately in a vacuum 
chamber. For these thermoplastics, this temperature is in the range of temp = 100-180 
0
C. 
After this the two parts are brought together with a force of 20-30 kN. The combined parts are 
then cooled to just below the glass transition temperature of the polymer and after some time 
the two are pulled apart. This method has been shown to results in high aspect ratio micro-
structures in both polymers [45].  
 
Figure 1: Schematic drawing of the hot embossing equipment 
 
Hot embossing is mostly used for devices involving capillary electrophoresis, but is also used 
to fabricate more complex structures and devices such as actuators. An actuator produced by 
one group was used to control the flow of paraffin in a particular device [46]. A 
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polycarbonate substrate was hot embossed with a silicon master electroplated with nickel by 
Klintberg et al.  
The three heating and cooling processes involved in hot embossing can be represented in 
Figure 2 below: 
 
Figure 2: Three stages of hot embossing 
[47] 
As stated before, hot embossing involves heating up to the glass transition temperature of the 
polymer, an embossing of the pattern into the polymer and the cooling and separating of the 
polymer from the mold. Hot embossing is thus a viable tool for the mass production of 
devices such as the one described in this work, and its use in the isolation of cell free foetal 
DNA. 
 
2.3.2. Laser Ablation 
 
The second method of microfabrication used in this work is known as laser ablation. This 
process involves the irradiation of solid material from a surface with the use of a laser beam. 
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Microfabrication of plastics is usually carried out using carbon dioxide (CO2) or excimer 
lasers [48]. Carbon dioxide lasers operate in the infrared region of the electromagnetic 
spectrum whereas excimer lasers operate in the UV range. Laser ablation usually removes 
material with a pulsed laser, but continuous wave lasers also exist. The pulse of the laser is 
what measures the speed and can vary in duration from milliseconds to femtoseconds.  
 
The most commonly used substrate for microfabrication with CO2 lasers is PMMA and PET 
[49]. This is because of the ease of control as well as the capabilities of PMMA to subsequent 
bonding methods. Other substrates have also been ablated by excimer lasers, such as 
polycarbonate (PC), polyimide, polyvinyl chloride (PVC), cellulose acetate and polystyrene 
(PS) [50]. As stated before, PMMA is one of the main substrates for CO2 lasers. For the 
purpose of this work, I will focus on this topic for review. PMMA plastic is commonly used 
as a substrate for the production of micro-capillaries for DNA electrophoresis. Laser 
fabrication of these devices allows for rapid, precise and reproducible products. Pfleging et al. 
was able to produce capillaries of less than 30 µm in width with an average deviation of 
around 3% [51].  The laser used had a continuous mode with a maximum beam power = 40 
W.  
 
The fact that direct-writing of a CO2 laser is fast has the negative side-effect of forming a 
rugged surface on substrates. This in turn results in a surface which has limited chemistry 
modification ability. However PMMA micromachining was shown to improve on these 
effects in a work by Cheng et al. [52]. A commercial laser scriber was used to design and 
engrave patterns onto the PMMA substrate. In order to overcome the surface roughness, a 
thermal annealing process was included to smoothen out the PMMA structures. Because of 
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the chemical characteristics of PMMA, it was possible to further modify the surface of the 
plastic. This was performed by a reduction reaction followed by organosilane chemistry. 
These reactions resulted in the introduction of functional groups such as perfluoroalkyl (–
CnF2n+2), amino (–NH2), and sulfhydryl (–SH) groups. These functional groups allow for 
surface passivation or further biomolecule immobilization. It has thus been sufficiently 
proven that CO2 lasers are suitable for the micro-fabrication of PMMA substrates in the 
development of biological devices.  
 
2.4. Capillary electrophoresis 
 
Capillary electrophoresis is considered an evolution of regular gel electrophoresis. In general 
terms, the equipment consists of an injection system, a separation capillary, a high voltage 
source, electrodes, electrode jars as well as detectors for the separation and analysis of 
molecules such as DNA. There are various separation techniques which exist for a capillary 
electropherograph. These include capillary zone electrophoresis, micellar electrokinetic 
capillary electrophoresis, capillary electrochromatography, capillary isotachophoresis, 
capillary gel electrophoresis, capillary isoelectric focusing and chiral separation methods [53].  
 
Capillary electrophoresis is one of the most commonly used techniques for DNA sequencing 
in recent years and has been widely used in the area of DNA analysis. DNA sequencing 
efficiency and accuracy using capillary electrophoresis is dependent on various factors such 
as the electric field strength, temperature, composition of the sieving matrices as well as 
capillary wall coating, DNA labelling and DNA sequencing performance [54]. For the 
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purpose of this work, we will consider only the parameters which affect the micro-fluidic 
device used.  
 
2.4.1. Effect of various parameters in capillary electrophoresis 
 
The sieving matrix which fills the capillary column largely effects the migration of molecules 
within the capillary. This has an influence on both experimental time as well as molecule 
resolution. Initially, cross-linked polyacrylamide matrices were used. However this matrix has 
a very limited lifetime and is not suitable for repeated use [55]. The cross-linked polymer was 
then replaced by a more robust linear form of acrylamide (LPA/linear polyacrylamide). This 
matrix has the added benefit of being replaceable in the capillary column [56]. Derivatives of 
acrylamide such as poly(dimethylacrylamide) or pDMA has also found application in CE. 
The fact that this polymer greatly reduces electro-osmotic flow (EOF) makes it advantageous 
as a sieving matrix. Another extensively used polymer in capillary electrophoresis is 
poly(ethylene oxide) (PEO). This polymer has the ability to dynamically coat capillary walls, 
has a low viscosity and thus requires a low pressure for filling of capillaries [57]. Cellulose 
based polymers such as hydroxyethylcellulose and hydroxypropylcellulose has also been used 
for separation of molecules such as DNA [58]. An ideal or universal polymer for all sizes of 
DNA sequencing or separation has not yet been found. Some polymers might be ideal for 
shorter fragments while others are better for longer fragments. Others might have a better read 
length while others have ideal viscosity. Thus it is important to optimise the sieving matrix 
specifically for the application on which it is used.  
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The sieving matrix generally contains a denaturing agent which improves the separation of 
different sized DNA fragments in capillary electrophoresis. The most common denaturing 
agent for gel electrophoresis is urea and sometimes derivatives thereof such as N,N-
dimethylurea and tetramethylurea [59]. Organic solvents have been used more commonly as a 
denaturing agent in capillary electrophoresis. Rocheleau et al. has made use of a 10% 
formamide content to improve denaturing ability of the sieving matrix [60]. Other denaturing 
agents include N-methylformamide [61] as well as 2-pyrrolidinone [62].   
 
The effect of temperature has also been shown to act somewhat as a denaturing agent. The 
increase in temperature to around 60 
0
C has been shown to improve resolution and separation 
efficiency in capillary electrophoresis [63].  
 
The voltage or electric field strength has an impact on read time as well as separation and read 
length. In this case a high voltage would speed up the migration time of DNA but have a 
negative impact on fragment separation and vice versa for a low voltage. A group at Iowa 
State University showed the positive effect of a low separation voltage to have excellent 
resolution of DNA [64]. The effect of this low voltage however extended the electrophoresis 
time to 7 h. Increasing the electric voltage from 75 V/cm to 600 V/cm reduced this to time = 
3-4 min, in the work of Muller et al. [65]. However the downside of this is that the read length 
dramatically decreased. Thus it is important to optimise this factor as well for every 
application used. 
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2.4.2. Applications of capillary electrophoresis 
 
Although capillary electrophoresis is widely and most commonly used for sequencing of 
DNA, it has numerous other applications. Capillary electrophoresis has found an application 
in forensics and toxicology. This was done by the investigation of illicit drugs in seized 
preparations as well as complex biological matrices. CE was used by a group to 
simultaneously differentiate between various drugs from a hair sample in 1995 [66]. Another 
group used capillary electrophoresis for the separation of over 50 metabolites from a urine 
sample. Generally, this clinical technique would be carried out using GC-MS (gas 
chromatography and mass spectrometry), but the use of CE reduces the time taken from over 
an hour to just 15 min [67].  Capillary electrophoresis can also be used in numerous clinical 
laboratory applications such as analysis of proteins, haemoglobin variants, lipoproteins, 
molecular diagnostics and many others [68]. 
 
2.5. DNA pre-concentration 
 
There are various means of on-chip pre-concentration of DNA samples in micro-fluidic 
devices. These include techniques such as field amplified sample stacking (FASS), 
temperature gradient focusing, electrokinetic trapping (EKT) and isotachophoresis (ITP). For 
the purpose of this work the last two techniques will be reviewed i.e. EKT and ITP. It is 
possible to work with larger sample volumes using these techniques and therefore they were 
applied in this research work.  
  
 
 
26 
 
 2.5.1 Electrokinetic Trapping 
 
Electrokinetic methods are one of the most popular techniques of pre-concentrating DNA in 
micro-fluidic devices. This is due to the possibility and advantage of using samples with a 
larger volume of a few microliters. EKT phenomena has been reported and explained by the 
hindrance of charged molecules (such as DNA) which enter channels or nano-sized pores. 
This hindrance is caused by charge exclusion [69]. Electrokinetic phenomena can occur in 
front of many other surfaces such as hydrogel plugs, nano-channels as well as membranes. A 
negatively charged hydrogel plug was successfully used within a channel in order to 
concentrate negatively charged analytes [70]. The charged analytes were concentrated in front 
of the hydrogel which contained pores of only a few nanometres (~20 nm). However this 
phenomenon of pre-concentration was found to be affected by a major redistribution of the 
local electric field. This was caused by development of CP (concentration polarization) zones 
and simultaneous generation of electro osmotic flow (EOF) that hindered pre-concentration. 
 
Electrokinetic interaction of charged or neutral molecules has also been studied in various 
depths of nano-channels. A group investigated the electrophoretic transport of 100-1000 bp 
DNA fragments in a fused silica channel of depth = 40, 100 and 1560 nm. This channel 
contained no sieving matrix or gel [71]. This group however showed that the 
electrokinetically-driven DNA separation in nano-channels needs further improvement in 
order to make accurate predictions. It is suggested that the surface of these nano-channels as 
well as the kinetics of adsorption/desorption play a big role in nano-channel electrophoresis 
[72].  
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Electrokinetic trapping in front of a membrane is particularly interesting for this work. This 
technique has used membranes with pores in the range of 2-200 nm in diameter. This size is 
larger than the sample molecule and thus disallows mechanical trapping. A polarization zone 
forms, in which the specific conductivity increases on the cathodic side of a cation-selective 
membrane. This zone causes the sample ions to decelerate and thereby concentrate in front of 
the membrane [73]. The use of poly(ethylene terephthalate) as a membrane for electrokinetic 
trapping has been proven successful in the past. This polymer provides a negatively charged 
surface [74] so as to exclude negatively charged molecules such as DNA. A microsystem was 
recently fabricated so as to incorporate this negatively charged PET membrane for the 
electrokinetic trapping and thereby pre-concentration of a DNA sample [75]. The use of 
electrokinetic trapping of DNA in front of a negatively charged membrane is thus a viable 
option for pre-concentration of a sample of a few microliters.  
 
2.5.2 Isotachophoresis 
 
Isotachophoresis (ITP) is a technique of concentrating or separating analytes which is 
applicable to many different samples. These include peptides [76], small ions [77], 
nanoparticles [78], pharmaceuticals [79] and in this case DNA. It is possible to analyse so 
many molecules using this technique because it is mostly dependent on a gradient within the 
buffer system and not so much a specific trait of the analyte. The buffer system consists of a 
leading (LE buffer) and terminating (TE buffer) electrolyte which contains fast and slow ions 
respectively, causing analytes to focus at the interface of the two under the influence of an 
applied electric field.  
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The application of this technique varies across a wide spectrum of analytes. A group, Prest et 
al. [80] used a complexing agent (malonic acid) in conjunction with isotachophoresis to 
concentrate and thereby quantify magnesium in a sample with many other analytes. The 
technique resulted in a limit of detection of 0.45 mg/L using 10 mM caesium hydroxide + 
pivalic acid, as LE buffer, 2 mM malonic acid, 1 g/L HEC as a sieving matrix and 10 mM tris 
as a TE buffer. Another group uses HEC at 0.08% concentration in the determination of 
neomycin. This group carried out ITP using a column switching commercial apparatus with 
conductivity detection. In this case the LE buffer consisted of 10 mM sodium acetate-acetic 
acid, HEC and TE buffer of 10 mM b-alanine. A limit of detection of 18.96 mg/L was 
achieved using this technique [81]. 
 
A type of isotachophoresis that takes place at the beginning of a capillary electrophoresis 
column is known as transient isotachophoresis or tITP.  A group has previously combined 
electrokinetic trapping and isotachophoresis in a single-channel microchip for analysis of 
DNA [82]. This group employed a single channel with length = 40.5 mm, width = 110 micron 
and depth = 50 micron. They found that using a focused electrokinetic injection and transient 
isotachophoresis as a pre-concentration protocol greatly improved the sensitivity of DNA 
analysis by chip electrophoresis. The group attempted to further improve on this work by 
using a different geometry of the micro-chip. A novel sample injection system was proposed 
and named floating electrokinetic supercharging. Here electrokinetic injection and ITP pre-
concentration was performed in a separation channel. This channel connected two reservoir 
ports with a cross-geometry micro-chip. A representation of the chip geometry is as shown in 
Figure 3 below: 
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Figure 3: Schematic drawing of cross-geometry microchip. Ports 1, 2, 3 and 4 are 
reservoirs 
 
The sample was eluted after pre-concentration using leading electrolyte ions in order to enable 
zone electrophoresis. This method allowed for a ten time increase in limit of detection as well 
as a higher resolution and shorter analysis time [83]. Isotachophoresis carried out in solution 
before the analyte enters the sieving matrix is known as free-solution transient 
isotachophoresis (FstITP) when coupled with capillary electrophoresis. The group found that 
the pre-concentration step in solution was much more rapid in free solution which resulted in 
higher separation efficiency in the subsequent CE step. This FstITP-CE method was found to 
be suitable for DNA samples with a high saline content and is also simple, robust and flexible 
[84].  
 
2.6. Lab on a Chip 
 
The incorporation of two or more of these laboratory techniques into a single device is the 
definition of lab on a chip. The demand for this technology increased in recent years because 
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of the need for faster, smaller and more efficient analytical techniques. Two technologies 
arose from this demand, the first being selective chemical sensors and the second being total 
analysis systems (TAS). The latter is considered lab on a chip technology. A TAS device 
ideally contains all the components necessary for automated analysis such as sampling, 
sample pre-treatment, chemical reactions, analytical separations, analyte detection and 
product isolation as well as data analysis [85]. Manz et al. first introduced the concept of 
micro-total analysis systems in 1990 as an alternative method for chemical sensing. This work 
discussed theories of hydrodynamics and diffusion which indicated that both faster and more 
efficient processes could occur in flow injection analysis, chromatography and electrophoresis 
in a micro-TAS. He stated that the smaller sample volumes will improve selectivity and also 
that the device allows for a multi-component system [86]. 
 
Lab on a chip (LOC) technology has various applications, as with any laboratory technique. 
LOC devices also have the added benefit of being tailor made and designed for any specific 
application. Devices have been successfully produced for the analysis or diagnosis of plant 
pathogens. A group developed a system for the rapid determination of nucleic acids specific 
for the Phytophthora species. This device consisted of two components, flexible and non-
flexible, with integrated micro-channels and micro-chambers. This device was capable of 
carrying out PCR steps and hybridisation of DNA sequences consecutively within a single 
device [87]. Another group took advantage of spectrophotometric detection for the 
characterisation of porcine oocytes. This micro-device consisted of micro-channels within a 
silicon substrate, buffers and optical fibres for detection of the oocyte as shown in Figure 4 
below: 
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Figure 4: Images of the lab on a chip device for visualisation of a porcine oocyte 
 
This group recorded the absorbance characteristics of the oocyte and stored it in a database. 
With this information in hand it was made possible to characterise and in future detect this 
cell [88] using the same device. 
 
Lab on a chip is not only limited to analytical and characterisation techniques, but can also be 
used for synthesis of various structures or morphologies. In one instance, machining and hot-
pressing of cyclic olefin copolymers were implemented to construct milli-fluidic LOC’s 
which are able to carry out on-chip bubble generation and flow chemistries. This phenomenon 
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was then manipulated to generate porous solids that are highly mono-dispersed and ordered 
[89]. LOC technology has also expanded to the field of proteomics. Research has been carried 
out in order to enable protein sizing using lab on a chip technology and its possible integration 
into mass spectrometry equipment. Automated and rapid protein sizing have been available 
on chips in the current commercial market. Most groups make use of capillary electrophoresis 
as an alternative to mass spectrometry for protein sizing [90].  
 
Microfabrication for on chip capillary electrophoresis of DNA is one of the most common 
techniques nowadays. A group was able to miniaturise an instrument for chip-based capillary 
electrophoresis of DNA with fluorometric detection. This device used a temperature control 
technique to change the mobility of DNA. Instead of the conventional plastic chips, this group 
made use of borosilicate glass substrates which contained micro-containers, a loading channel 
and separation channel for DNA analysis [91]. Lab on a chip technology in the form of DNA 
microarrays have also shown promise as an analytical tool or for the detection of cell free 
foetal DNA. Larrabee et al. [37] used comparative gene analysis by comparing the male 
specific SRY gene and X-chromosome markers for rapid screening of samples. In this way it 
is possible to carry out many experiments in parallel and obtain huge amounts of genetic 
information in a fraction of the time it would have taken using conventional DNA sequencing.  
 
Cell free foetal DNA has been largely studied and efforts are constantly being made for the 
efficient and accurate separation and/or analysis of this DNA in order to carry out non-
invasive prenatal diagnostic tests. It is thus natural that a lot of the studies are taking place on 
the micro-scale and have an application in LOC technology. Kubicki et al. has developed a 
glass LOC specifically for the size separation of cell free foetal DNA from a maternal sample. 
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In this case the group used synthetic DNA within the size range of foetal and maternal DNA 
and separated them within a borosilicate glass micro-fluidic device. The DNA was then 
detected using a laser and CCD camera for monitoring of fluorescent signals. They found that 
the DNA in a range of 20-500bp was separated in the device within time = 2 min, allowing 
for efficient extraction of DNA [92]. The work in this dissertation is an alternative to the 
technique described above which also employs size discrimination as a method of isolating 
cell free foetal DNA. 
 
  
  
 
 
34 
 
CHAPTER 3 
 
3.0. METHODOLOGY 
 
The fabrication of the micro-fluidic devices and analytical methods used in this experimental 
work are all described in detail below: 
 
3.1. Hot Embossing 
 
This method was used to fabricate the micro-fluidic device that contained the various 
components and reservoirs as can be seen in Figure 10 in section 4.4. Hot embossing is a form 
of micro-thermoforming of a substrate. In this case, a thermoplastic such as PMMA can be 
moulded into a specific shape with the help of a stamp as well as an increase in temperature. 
The stamp and substrate are placed into holders within the embossing equipment. The two 
pieces are then heated to a temperature just above the glass transition, Tg, of the polymer. The 
glass transition temperature is a thermal transition that a polymer undergoes where it softens 
because of the onset of long range molecular motion. This causes a change in the free volume 
of the polymer which can be represented by the graph below with a comparison of stiffness of 
polymer as a function of temperature in Figure 5 below, where Tm is the melting temperature 
of the polymer: 
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Figure 5: Graphical representation of glass transition temperature. (Stiffness versus 
temperature) 
 
After this temperature is applied, the master and polymer substrate are brought into contact 
and pressed together under pressure and vacuum. This process occurs in two steps as a part of 
the molding cycle. The first step consists of the mold and polymer substrate moving toward 
each other at a speed of approximately 1 mm/min. This is done until the preset maximum 
embossing force is reached. This embossing force is kept constant for a period of time, known 
as the holding time which occurs in the second step of the molding cycle. In order to obtain a 
constant force between the two parts, the movement between tool and substrate has to be 
controlled. During the holding time, the heated polymer is allowed to flow in a radial 
direction while the remaining layer undergoes reduction under this applied force/pressure. At 
all stages in the holding time the temperature remains constant under vacuum. This is required 
in order to fill all the cavities of the mold completely as well as to eliminate the inclusion of 
air which might result in an incomplete filling of the mold. When the preset holding time is 
complete, the cooling step of the hot embossing protocol begins. This is continued until the 
temperature of the polymer substrate reaches just below its glass transition temperature. This 
can be called the demolding temperature i.e. the temperature at which the polymer substrate 
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and the mold are separated. For demolding to be successful, the adhesion between mold and 
substrate has to be less than the adhesion between substrate and the plate/holder. Because of 
these adhesive properties, the demolding occurs in such a way that it is both homogenous and 
vertical to the molded part. The process of demolding is the most critical for successful 
pattern transfer in hot embossing and can be influenced by a variety of factors. Inefficient 
demolding might even result in the destruction of the products microstructures [93]. A 
representation of the various processes is as shown in Scheme 2 below: 
 
 
Scheme 2: Hot embossing Process 
 
3.2. Laser Ablation/microfabrication  
 
Laser ablation is another method with which to produce features of the micro-scale onto 
plastic substrates. Laser microfabrication can exist in three different forms or techniques, 
infrared laser micromachining, laser-induced micro-joining and femtosecond lasers.  
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The first type of laser microfabrication, infrared laser machining is based purely on thermal 
evaporation of material. This is carried out by applying a high heat in the form of a laser 
beam. This laser has an output wavelength in the infrared region of the electromagnetic 
spectrum. Laser micro-joining is mainly used as a method of welding together biocompatible 
components such as plastics to metal or glass parts. Laser welding of polymers can be 
performed using infrared radiation (with either an Nd: YAG laser, emitting at a wavelength = 
1064 nm, or diode lasers emitting in a range of wavelength = 808 and 980 nm), which 
corresponds to a transmission window of the polymers. The transmission welding technique 
based on heating plastics via surface absorption can also be applied to produce a joint 
between two overlapping polymer substrates, one which acts as the transmitting and the other 
as the absorbing layer of plastic [94]. Femtosecond lasers can be used for laser 
ablation/microfabrication of plastics and its application to micro-devices. These lasers have 
the ability to produce light pulses of extremely short duration in the order of femtoseconds 
(time = 10
-15 
s). [95]. One of the common lasers which act at this speed pulse is the carbon 
dioxide laser. 
 
Carbon dioxide lasers are one of the most efficient and powerful lasers operating in the 
middle infrared region. These can exist in both the pulsed and continuous wave forms. There 
are several different types of gas discharge configurations that consist of not only CO2, but 
also nitrogen and helium. These lasers are able to produce powers of more than 100 kW with 
pulse energies of up to 10 kJ. This is because of the rotational-vibrational transitions of the 
CO2 molecule. The laser can exist in one of three structures: Longitudinally excited lasers 
which are in the form of a long, narrow, cylindrically shaped glass enclosure with electrodes 
at opposite ends from which the discharge excitation current is introduced; waveguide lasers 
which have two transverse radio-frequency (RF) electrodes that are separated by insulating 
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sections which form a bore region. The bore region acts as a waveguide by reflecting the 
beam off the insulating material; and finally transversely excited lasers which operate at 
height total gas pressures of 1 atmosphere or more. This allows for a higher energy output per 
unit volume of gas. [96] 
 
The laser beam is focused onto the surface of the substrate using parameters which are preset 
according to the specific requirements of the device, in this case a plastic micro-fluidic 
device. As the laser moves across the substrate surface, the polymer or plastic melts and some 
immediately forms a vapour, while the rest forms a pool of molten polymer on the surface. 
This pool moves away from the beam in all directions, driven by the heated gas of vaporised 
plastic. Most of the melted polymer re-solidifies, and in this way the laser beam is able to cut 
out channels and wells into a polymeric substrate. A schematic diagram of this process can be 
represented in Figure 6 below:  [49] 
 
Figure 6: Micromachining by CO2 laser 
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Both hot embossing and laser microfabrication can be used to make various micro-devices. In 
this work it was used to produce micro-fluidic devices for the pre-concentration and size 
separation of DNA and its application in isolating cell free foetal DNA. The processes 
occurring in the device will be reviewed in the following sections. 
 
3.3. Electrokinetic Trapping 
 
Conventional electrophoresis is based on the ratio of charge and size of the analyte particle. 
The electrophoretic force is directly proportional to the electric field applied as represented by 
the equation 1 below: 
          Eq 1 
 
The electrophoretic force in this case is fep, z is the effective charge on the molecule, F is 
faradays constant and E is the electric field. [97]. Dielectrophoresis however refers to the 
effect of an applied electric field gradient on a polarizable particle. When this particle is more 
polarizable or charged than the surrounding medium the particle experiences positive 
dielectrophoresis and when the particle is less polarizable than the surrounding medium, the 
particle is repelled by the regions of high field gradient or negative dielectrophoresis. In our 
case this can be explained as electrokinetic trapping. The dielectrophoretic force on the 
particle can thus be expressed as the following equation 2 
 
          
       Eq 2 
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The dielectrophoretic force is thus represented by fdep, m is the permittivity of the medium, r is 
the particle radius, E is the strength of the electric field and K is the Clausius-Mosotti factor. 
This value is dependent on the conductivities and permittivities of the medium and particle of 
the frequency of the applied field [98]. As shown, the dielectric force is proportional to the 
field gradient rather than the strength of the applied field and thus independent of the 
direction of the applied field. The dependence of frequency in K, the Clausius-Mosotti term, 
is due to the polarizability of dielectric particles dependence on the frequency of the applied 
field. The existence of this frequency is what allows particles such to either be trapped or 
repelled by the high field gradient by adjusting the frequency. This allows for 
dielectrophoresis trapping or pre-concentrating a particle of interest [99] [100]. 
 
Electrokinetic trapping in this case is a type of DNA concentration step occurring in front of a 
negatively charged membrane of poly(ethylene terephthalate) or PET. This membrane is 
characteristically negatively charged and placed in between a fluidic chamber and micro-
channel. The fact that the PET membrane is permiselective induces a concentration 
polarization which exists near the channel. This occurs as an electric field is applied between 
an anodic or cathodic compartment and reservoir with the membrane connecting the two. The 
PET membrane consists of nanopores which have a diameter = 100 nm. Negatively charged 
ions or molecules such as DNA become trapped within the cathodic compartment of the 
membrane when the overlapping Debye layers in the nanopore disallow access of DNA to 
pass through the pore. The ionic strength in the cathodic compartment increases because 
anions in the electrolyte also experience the same type of charge exclusion as DNA. This in 
turn causes cations to decelerate because of the lower electric field in the region closer to the 
membrane in the cathodic compartment. Another factor which contributes to the increase in 
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local electric field is the fewer anions which pass through the membrane into the anodic 
compartment close to the negatively charged nanopores of PET. For membranes with 
permiselective nanopores, a space charge exists which is a charge depletion zone on the 
anodic side of the nano-channel [101] [102]. 
 
When considering that the entire system is continuous, one can describe the ion flux with the 
Nernst-Planck equation 3 as follows: [75] 
 
   
  
                   
  
        
   
  Eq 3 
 
This equation describes the motion of chemical species is a fluid medium. The ionic 
concentration gradient is    , uhydr is the fluidic counter flow velocity, t is time, Di is the 
diffusion constant, c is the concentration of the species, z is the valence of the ionic species, e 
is the elementary charge, kB is the Boltzmann constant and T is temperature,   is the electric 
potential. The local electric potential and local concentration of ions can be described by the 
Poisson equation 4, 
 
       
  
    
 
  
    
 
  
    
 
 
    
 ∑       Eq 4 
 
where    is the volume charge density of the electrolyte,    is the volume fixed charge 
density of the membrane, F is the Faraday constant, and ε0 and εr are the permittivity of the 
vacuum and dielectric constant, respectively. 
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In conclusion, it can be said that a counteracting fluid flow is required for efficient trapping 
and concentration of DNA in front of 100 nm pore PET membranes. The velocity of ions 
increases in the field amplified sample compartment and the PET membrane shows a stronger 
wall potential which acts on the anions resulting in more efficient trapping of DNA. 
 
3.4. Isotachophoresis 
 
Isotachophoresis (ITP) is derived from the Greek words iso which means equal, tachos which 
means speed and phoresis which means migration. Thus, the words liberal translation means 
migration at equal speed. [103]. The ITP process is a method of pre-concentration of DNA 
which requires a discontinuous buffer system that consists of a leading and terminating 
electrolyte. The fast leading electrolyte has a higher ionic concentration than the slower 
terminating electrolyte. As in electrophoresis, a voltage is applied which causes DNA to 
migrate. However, in ITP a low electric field is formed in the leading electrolyte and a higher 
electric field in the terminating electrolyte, causing a stacking of DNA between the two. This 
step of pre-concentration can be done in conjunction with capillary electrophoresis in order to 
couple pre-concentration and separation in a single unit. This is known as transient 
isotachophoresis [104]. tITP requires a separating matrix so that the DNA can stack in front of 
it, followed by size separation within it. In addition to the fact that ITP stacks charged 
molecules of the same electrophoretic mobility, it also allows for separation of molecules with 
different electrophoretic mobility. This method of pre-concentration was used in conjunction 
with electrokinetic trapping and followed by separation of DNA by capillary electrophoresis 
within a single device in this work.  
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3.5. Agarose gel electrophoresis  
 
DNA gel electrophoresis is a method of separating DNA according to size. This is carried out 
by applying an electric field in order to move the negatively charged DNA molecules through 
the gel matrix. The term gel refers to a matrix which contains and separates DNA molecules. 
The gel is generally a cross-linked polymer of a certain composition and porosity based on its 
concentration. Agarose is however composed of long un-branched chains of carbohydrate 
without crosslinks, unlike the alternative; acrylamide. Separation is carried out by placing the 
DNA in a well within the gel and applying an electric field in such a way that the negatively 
charged DNA migrates towards the positively charged anode. DNA molecules separate 
according to the length of the DNA fragment. This phenomenon can be explained by the 
relation between electrophoretic mobility and size.  
 
The Einstein relation as shown in equation 5 shows the dependence of the diffusion 
coefficient on electrophoretic mobility. 
   
      
  
  Eq 5 
 
In this case z represents the number of charged species in the ion and e is the elementary 
charge. The diffusion coefficient can be altered in the case of nucleic acids. A macromolecule 
such as DNA underlies a rotational (Dr) and translational diffusion coefficient (Dt) [105]. The 
diffusion coefficient (Dr) for a rod like molecule can be represented as follows in equation 6 
[106]: 
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  Eq 6 
 
p is the axial ratio (p = L/d) with the end-to-end length (L) of the nucleic acid chain, d is the 
diameter, the correction factor (δ), thermal energy is represented by (kBT) and η represents the 
viscosity. The translational diffusion coefficient is thus represented by the equation 7 below 
[106]: 
     
              
    
  Eq 7 
 
In this case, ν is a correction for end effects and is given by v = 0.312 + 0.565/p - 0.1/p2 
[105]. A measure for the end-to-end length of polymers which is sometimes consulted to 
model DNA polymers can be derived from the Zimm model [107] [108]. The diffusion 
coefficient is dependent on the electrophoretic mobility which is in turn dependent on the size 
of the DNA molecule. The electrophoretic mobility of double stranded DNA increases with 
an increase in chain length until approximately 500 bp, after which it remains constant above 
this length [109].  
 
3.6. Capillary Electrophoresis 
 
Size separation of DNA can also be carried out in long capillary tubes instead of a slab of gel. 
Capillary electrophoresis is designed to separate species according to their size to charge ratio 
within a capillary that is filled with electrolyte. The separation is also dependant on the 
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migration of analytes in an applied electric field. The electrophoretic migration velocity (  ) 
of an analyte toward the electrode of opposite charge is as shown in equation 8: 
          Eq 8 
 
, where   the electrophoretic mobility and E is the electric field strength. The value of 
electrophoretic mobility of an analyte is directly proportional to its ionic charge and inversely 
proportional to frictional force that exists in the buffer. Thus, two different analytes in a 
sample would separate from each other should they have different charges or experience 
different frictional forces. Frictional forces within the buffer system are dependent on factors 
like viscosity (η) as well as the size and shape of the ion [110]. Thus the electrophoretic 
mobility of an analyte can be expressed as shown in equation 9: 
 
    
 
    
  Eq 9 
 
Where   is the net charge of the analyte and   is the Stokes radius of the analyte. The Stokes 
radius is given by equation 10: 
   
   
    
  Eq 10 
 
Where T is the temperature and     is the Boltzmann constant, D is the diffusion coefficient. 
The equations above prove that the electrophoretic mobility,     of an analyte is directly 
proportional to the charge of the analyte and inversely proportional to its radius. Therefore, an 
analyte with a higher charge would have a lower electrophoretic mobility and an analyte with 
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a larger radius would have a smaller electrophoretic mobility. The value of    can also be 
determined experimentally from the migration time and field strength as shown in equation 
11. 
    ( 
 
   
) ( 
  
   
)  Eq 11 
 
, where L is the distance from the inlet to the detection point, tr  is the time required for the 
analyte to reach the detection point (migration time), V  is the applied voltage (field strength), 
and Lt is the total length of the capillary [110]. The speed at which an analyte migrates is also 
dependent on electro osmotic flow (EOF) of the buffer system.  Analytes migrate towards the 
electrode of opposite charge while being separated by differences in electrophoretic mobility. 
Therefore positively charged analytes migrate toward the cathode and negatively charged 
analytes migrate toward the anode. The speed of the electro osmotic flow,    can be 
represented as follows 
          Eq 12  
 
Where     is the electroosmotic mobility, which is defined as: 
    
  
 
   Eq 13 
 
, where   is the zeta potential of the capillary wall, and   is the relative permittivity of the 
buffer solution. The speed of migration of an analyte in the electric field can be represented 
by the following equation:  
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       (      )   Eq 14 
 
All analytes are carried along with the buffer system towards the cathode since the electro 
osmotic flow of the buffer is generally greater than that of the analyte. Analytes with a larger 
negative charge move more slowly through the capillary column due to their conflicting 
electrophoretic mobility’s [110]. Electro osmotic flow exists when the electric field is applied 
to a capillary column that contains solution as well as charges within the capillary wall. The 
effect of EOF can be diminished using solvents such as sodium hydroxide.  
In order to calculate the resolution (  ) of analytes such as DNA in conventional capillary 
electrophoresis once can use the following equation: 
 
    
 
 
 ( 
   √ 
      
)  Eq 15 
 
According to this equation, resolution is best when the electrophoretic and electro osmotic 
mobility’s are similar in magnitude and opposite in sign. It can also be seen that high 
resolution requires lower velocity as well as an increased analysis time. In the equation above 
  is the apparent mobility in the capillary column, and N is the number of theoretical plates 
which can be represented as follow: 
   
  
    
  Eq 16 
 
The number of theoretical plates represents the efficiency of separation in this case. Here,  
   is the diffusion coefficient of the analyte. Here it seems that the efficiency of separation 
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is limited by diffusion of analytes and is directly proportional to the electric field strength. In 
the case of this device, we could also determine the resolution as the level of DNA separation 
when exiting the capillary column. Thus a better resolution would be the seen as a larger 
distance separating each DNA fragment when exiting the device.  
 
3.7. Bioanalyser 
 
The Agilent Bioanalyser uses a type of lab on a chip technology for the analysis of DNA, 
RNA, proteins and even whole cells. This uses a micro-channel based electrophoretic cell that 
provides fast and accurate determination of these molecules. An example of this micro-
channel device is shown below: 
 
Figure 7: Agilent Bioanalyser micro-channel chip (A) external appearance of chip (B) 
inner architecture of chip 
[111] 
The chip contains 16 wells, 3 for loading the capillary gel dye mix, 1 for the molecular size 
ladder used as a reference and 12 for experimental samples. It also contains connected micro-
channels which are filled with a sieving polymer and fluorescent dye i.e. the gel dye mix. For 
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the size determination of DNA fragments, the DNA will pass through these micro-channels 
under the influence of electrodes which create electrokinetic forces. This is very similar to the 
theory behind capillary electrophoresis. DNA fragments are thus intercalated with the 
fluorescent dye, separated by size and detected by a laser based detector within the Agilent 
Bioanalyser equipment. This equipment is known to have a limit of detection of down to 5 
pg/µl [112].  
  
3.8. Fluorescence Spectroscopy 
 
Fluorescence spectroscopy is a type of spectrochemical method for analysis of molecules. 
During fluorescence, a molecule is irradiated by light at a certain wavelength and emits 
radiation of a different wavelength. This is made possible because of the fact that molecules 
have various states referred to as energy levels. The molecule or species is excited when a 
photon is absorbed and transitions from its ground state to one of the vibrational states in the 
excited state. Inter-molecular vibrations cause excited molecules to lose energy and drop to a 
lower vibrational state in the excited state. This process of excitation and loss of energy is 
represented by the Jablonski diagram shown below in Figure 8: 
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Figure 8: Jablonski Diagram representation of fluorescence 
 
The species loses even more energy and drops back down to the ground electronic state and 
emits a photon in the process. This photon will have different energy and frequencies since 
the molecules might drop to any of the various vibrational levels. The photon emitted can be 
visualised as fluorescence.   
 
Some proteins or small molecules are naturally fluorescent and others can be labelled with an 
intrinsic fluorophore. This fluorophore can either be a fluorescent dye, a small molecule or a 
quantum dot. The fluorophore used in this specific experiment is Rhodamine 6G. This 
molecule has an absorption/excitation wavelength of, λabs = 525 nm and an emission 
wavelength of, λem = 555 nm. The absorption/emission spectra as well as the structure of 
Rhodamine 6G is as shown in Figure 9 below: 
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Figure 9: Absorption/excitation and emission spectra of Rhodamine 6G  
 
Rhodamine 6G can be attached to nucleic acids and act as a label for DNA detection. Organic 
fluorophores such as Rhodamine 6G fluoresce due to the delocalised electrons which are able 
to jump a band and stabilize the energy which the molecule absorbs. Therefore most organic 
fluorophores are conjugated systems. 
 
As stated before, fluorescence comes from the relaxation of a molecule from its singlet 
excited state to its singlet ground state. The wavelength of a molecules’ fluorescence is 
dependent on the energy gap between these excited and ground states. The overall energy 
associated with fluorescence can be described below in equation 17: 
                                 Eq 17 
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,where Efluor is the energy of the emitted light, Eabs is the energy of the light absorbed by the 
molecule during excitation, and Evib is the energy lost by the molecule from vibrational 
relaxation. The Esolv.relax term comes from the necessity of a solvent cage of the molecule. This 
is necessary for the molecule to reorient itself in the excited state and then again when the 
molecule relaxes to the ground state. As shown in the equation above, the energy of 
fluorescence is always lower than the absorbed energy. This is why the emitted light always 
has a longer wavelength than the wavelength of excitation. 
 
3.9. Real Time PCR 
 
Real time polymerase chain reaction is a method of amplifying a specific DNA target. This is 
an extension of the conventional polymerase chain reaction that has existed since 1983. Dr 
Kary Mullis pioneered the development of this technique while working for Cetus 
Corporation, one of the first companies working in biotechnology. The polymerase chain 
reaction involves heating and cooling steps that allow amplification within a tube. The tube 
contains various components which allow for this amplification. These include: 
 the target DNA: the DNA template that contains the sequence which is to be 
amplified 
 
 free nucleotides (deoxynucleoside triphosphates, dNTP’s) which are the building 
blocks of DNA i.e. single units of DNA bases A (Adenine), T (Thymine), G 
(Guanine) and C (Cytosine)  
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 forward and reverse primers, these are short strands of single stranded DNA which 
are complementary to the beginning and end of the target sequence and act as the 
starting point of the polymerase reaction,  
 
 Taq polymerase, a type of enzyme that is capable of synthesising new strands of 
DNA. Taq polymerase is the most commonly used enzyme in PCR and RT-PCR, 
it originates from Thermis Aquaticus and is capable of acting at high temperatures 
 
 Buffer solution, which provides a suitable chemical environment for stability of 
DNA polymerase as well as optimal conditions for the amplification of DNA 
 
 Divalent cations, such as Mg2+ which acts as a co-factor for the DNA polymerase 
enzyme  
 
Each PCR experiment requires optimisation in each of the various components. Generally 
these reactions occur in small tubes of volume = 0.2-0.5 mL, but the volume of the actual 
reaction mixture is around 10-200 µL. These tubes are then placed in a thermo cycler that 
allows for the reaction to occur. PCR is basically a series of heating and cooling steps which 
allow for DNA amplification. Typically, these steps consist of about 20-40 cycles of heating 
and cooling. Each of these cycles contains three steps.  
 The first step involves denaturation of the template DNA. In this case the PCR-tube is 
heated up to around temp = 95 
0
C for time = 20-30 s. At this point the double stranded 
DNA breaks and forms two single strands of DNA. 
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 The second step is annealing of the DNA primers and occurs at a temperature = 50-60 
0
C. The exact temperature of annealing depends on the melting temperature of the 
primers involved. Once the primers are annealed to the DNA template, the Taq 
polymerase binds to the primer-template hybrid and DNA extension can then take 
place 
 
 The final step of each cycle is known as elongation and the temperature of this step is 
dependent on the type of DNA polymerase used.  Taq polymerase has optimal activity 
of around temp = 75-80 
0
C and would thus be the elongation temperature if this 
polymerase enzyme is used. If another DNA polymerase is used, the temperature of 
the elongation step would be appropriately adjusted. The polymerase enzyme makes 
use of the free dNTP’s in solution to extend the DNA strand by adding it to 
complementary DNA bases in the template DNA. The time that it takes to elongate the 
DNA depends on the length of the DNA template as well as the DNA polymerase 
enzyme.  
 
Once each cycle is complete, it is then repeated 20-40 times as stated before. After every 
cycle the amount of DNA present in the tube doubles and thus allows for exponential 
amplification of the target DNA. This amplification continues until all the reagents are used 
up within the PCR tube or until the DNA polymerase enzyme is loses its activity. A scheme 
representing conventional PCR is as shown below: 
 
  
 
 
55 
 
 
Scheme 3: Conventional PCR protocol 
 
In comparison, real time PCR is very similar to conventional PCR explained above. It 
contains all the components stated above with minor modifications. Conventional PCR 
products are usually quantified using agarose gel electrophoresis, northern blot or southern 
blot, and thus require two steps i.e. amplification and then quantification. Real time PCR 
allows for simultaneous amplification and quantification. This is made possible by the 
inclusion of a fluorescent probe into the protocol with Taq polymerase as enzyme. This is a 
single strand of DNA that is complementary to a sequence of DNA within the template and is 
known as the fluorescent reporter probe. The strand of DNA is labelled with a fluorophore 
and quencher and produces a signal during amplification. The reaction mixture is prepared 
with addition of the quenched reporter probe. During the annealing stage, the reporter probe 
binds to the complementary sequence on the DNA template at the same time as the DNA 
primers. During elongation, the Taq polymerase acts in a 5ʹ-3ʹ direction as an exonuclease 
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enzyme thereby degrading the probe. As the probe is degraded, the quencher activity is 
diminished and a fluorescent signal is produced. This signal is measured in real time and its 
increase corresponds to the amount of product and can be used to determine the threshold 
cycle (Ct). The threshold cycle in real time PCR is known as the amount of cycles needed to 
cross the background signal threshold. The Ct value is inversely proportional to the 
concentration of DNA target. The increase in fluorescent signal is thus directly proportional to 
the concentration of DNA target. Other methods of quantification in RT-PCR include the use 
of double stranded DNA binding dyes such as SYBR green. In this case the dye binds to all 
dsDNA and produces a signal which is measured after each cycle since it theoretically would 
bind to the amplification product. 
 
DNA is quantified in real time PCR by plotting fluorescence versus the number of cycles on a 
logarithmic scale. The Ct value is set as a threshold for the fluorescent detection as a way of 
eliminating the background noise. In order for the protocol to be more reliable a series of 
dilutions of DNA is prepared to create a standard curve to monitor the change in Ct for each 
dilution. The slope of the linear plot is then used as a way of determining the efficiency of the 
RT-PCR amplification. Another difference between conventional PCR and real time PCR is 
the fact that RT-PCR takes place in a plate with 96 or 384 wells. Each individual well 
contains an individual PCR experiment that is monitored using the RT-PCR equipment.  
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CHAPTER 4 
 
4.0 EXPERIMENTAL WORK I 
 
4.1. Materials 
 
The PMMA micro-fluidic chips were fabricated by hot embossing and the microstructures 
milled out at the Institut für Mikrotechnik Mainz (IMM). Acrylamide, urea, N, N dimethyl 
acrylamide, ammonium persulfate (APS), tris(hydroxymethyl)aminomethane (tris), N,N-
dimethylurea, EDTA (ethylenediaminetetraacetic) acid and glycine were obtained from Sigma 
Aldrich. N,Nʹ-methylenebisacrylamide (Bis) solution and TEMED 
(tetramethylethylenediamine) was purchased from Bio-Rad. PET membranes with pore size = 
100 nm were purchased from Sterlitech Corporation. Agarose NA was purchased from GE 
Healthcare. GelStar (Lonza Group Ltd) served for staining electrophoresis gels and was 
purchased from Invitrogen. Hydroxypropylcellulose (HPC), hydroxyethylcellulose (HEC), 
polyvinylpyrrolidone (PVP) and 2-pyrrolidinone were also purchased from Sigma Aldrich. 
Linear polyacrylamide was purchased from GenomeLabTM. 
 
Synthetic DNA ladder was purchased from SERVA electrophoresis GmbH. The DNA 
consisted of 11 fragments with the following size: 100, 150, 200, 300, 400, 500(2), 600, 700, 
800, 900 and 1000 bp. A single strand of fluorescently labelled DNA was also used and 
purchased from Biomers.net. This DNA was 42 bp in length and was labelled with a 
Rhodamine 6G fluorophore with the following sequence: 
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5’-acc att aaa gaa aat atc att ggt gtt tcc aat ttt ttt ttt-3’ 
The Rhodamine 6G fluorophore was attached to the 5’ end of the DNA strand. 
 Real DNA samples were extracted from a maternal plasma sample of a pregnant mother 
carrying a male foetus. These samples obtained from the Molecular Genetics Thalassaemia 
Department at The Cyprus Institute of Neurology and Genetics (CING) in Nicosia, Cyprus. 
The DNA was suspended in a volume = 100 µL of nuclease free water and used for pre-
concentration and size separation within the microfluidic device. 
 
4.2. Buffers and solutions 
 
All solutions were prepared in Milli Q water (Millipore Inc. Ω = 18 M Ω cm-1). Leading 
electrolyte (LE buffer) consists of 50 mM trisHCL at pH 8.5. Terminating electrolyte (TE 
buffer) consists of 5 mM tris, 27.5 mM glycine at pH 8.5. 1X TBE buffer consisted of 89 mM 
tris, 89 mM Boric acid and 2 mM EDTA. 
 
4.3. Instrumentation 
 
A SynRad CO2 (carbon dioxide) laser with a Fenix Flyer marking head was used for the 
fabrication of the capillary column chips. During the experiment, a high voltage sequencer 
HVS 448-3000D was used to carry out all the processes within the micro-fluidic device, 
including pre-concentration and DNA size separation. For optimisation using the Rhodamine 
6G labelled DNA, a Cary 100 Bio (Varian) spectroflourimeter was used to analyse DNA 
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fractions at an excitation wavelength of 525 nm and emission wavelength of 555 nm. 
Optimisation of the protocol with the DNA ladder fragments was analysed using 2% Agarose 
gel electrophoresis. This type of DNA analysis was also carried out with an Agilent 
Bioanalyser and NanoDrop Spectrophotometer. Real Time PCR experiments were carried out 
using HT 7900 Life Technologies RT-PCR equipment. 
 
4.4. Micro-fluidic device preparation 
 
Poly(methyl methacrylate) (PMMA) chips, as shown in Figure 10 below, were cleaned by 
sonication in three solvents. The device was sonicated in isopropanol for 3 min in order to 
remove any organic matter from the micro-fluidic device, secondly in 0.5 M sodium 
hydroxide (NaOH) for 5 min and finally in Milli Q water for 10 min. The device was then 
dried under stream of nitrogen gas.  
 
Figure 10: Design of micro-fluidic device: (1) cathode reservoir (2) anode reservoir I (3) 
sample reservoir, (4) membrane (5) chamber sample inlet, (6) anode reservoir II, (7) 
recovery outlet (8) anode channels (9) a T-crossing valve and (10) a separation channel  
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A 3 mm PET membrane with 100 nm pore sizes was punched and welded into the membrane 
chamber (4) of the device at 160 
0
C for 2-3 s. Thereafter both sides of the device were 
covered with poly(propylene) adhesive foil. Holes (1), (2), (6) and (7) were cut out to allow 
for addition of buffers and the matrix of the capillary column. A platform and syringe was 
used to flush the anode channel with TE buffer. Thereafter the separation matrix was added to 
the capillary column [10]. 
 
The separation matrix was prepared as follows: 9% monomer solution (acrylamide or N,N-
dimethylacrylamide) with 2% Bis (N,Nʹ-methylenebisacrylamide) and 3 M N,N-dimethylurea 
was dissolved in either LE buffer or 1X TBE buffer in an eppendorf tube. A 2% solution of 
ammonium persulfate (APS) and TEMED (tetramethylethylenediamine) was used to initiate 
polymerisation of the matrix; the tube was then vortexed to assist thorough mixing after 
which a 5 µL volume was quickly added to hole (7) until it reaches the T-crossing valve. 
Polymerisation can be tracked by monitoring the leftover mixture in the eppendorf tube. After 
the matrix has solidified, LE buffer is added to the anodic reservoir (6) as well as hole (7) to 
keep the matrix moist. A connection should exist between reservoir (6) and hole (7). The 
dilute DNA sample (synthetic or real) of 80 µL is denatured at 95 
0
C for 10 min and then 
cooled to room temperature on ice before being added to the sample chamber via hole (5). 
The anodic reservoir (2) and cathodic reservoir (1) is filled with TE buffer while anodic 
reservoir (6) is filled with LE buffer. The microfluidic device is now ready for the 
experiment. This process can be summarised as shown in scheme 2 below: 
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Scheme 4: Preparation of the micro-fluidic device 
 
Platinum electrodes are inserted into the anodic and cathodic reservoirs and connected to a 
high voltage sequencer in order to apply a certain potential. Electrode A is placed in anodic 
reservoir (2) and A grounding is placed in cathodic reservoir (1). Electrode B is then placed in 
anodic reservoir (6) such that a potential gradient can exist on either sides of the capillary 
column. An image showing the setup of the experiment is shown in Figure 11 below: 
DONE! 
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Figure 11: Experimental Setup 
  
  
 
 
63 
 
The three processes within the general experimental protocol can be represented in table 2 
below: 
Table 2: Steps occurring during general experiment 
Time (s) Method Voltage (V) Comments 
0-300 EKT 1000 
Pre-concentration of DNA in front of 
PET membrane 
300 - - 
Hole 9 is pierced to allow DNA transport 
from in front of the PET membrane to in 
front of the matrix in the capillary 
column 
301-350 ITP 250/300 
DNA concentrates in front of sieving 
matrix 
351-360 Break None 
All electrodes are floating 
361-end CE 180 
DNA separates in the sieving 
matrix/capillary column and DNA 
fraction are collected every 30/60seconds 
  
The two pre-concentration steps i.e. electrokinetic trapping and isotachophoresis as well as 
the process of DNA separation in this case i.e. capillary electrophoresis will be explained in 
further detail in sections 4.6 - 4.7. 
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4.4.1. Column device preparation 
 
The preparation of the column micro-fluidic device is slightly different to the protocol as 
explained above and will be explained separately in this section so as to avoid confusion.  
Poly(methyl methacrylate) (PMMA) chips such as the one shown in Figure 12 below, were 
cleaned by sonication in three solvents. The device was sonicated in isopropanol for 3 min in 
order to remove any organic matter from the micro-fluidic device, second in 0.5 M sodium 
hydroxide (NaOH) for 5 min and finally in Milli Q water for 10 min. The device was then 
dried under stream of nitrogen gas. 
 
 
Figure 12: Design of column device: (1) Cathodic reservoir (2) Sample reservoir (3) 
Separation channel (4) Recovery outlet (5) Anodic reservoir 
 
Both sides of the device were covered with poly (propylene) adhesive foil and holes (1), (2), 
(4) and (5) were cut out on one side using a scalpel. Thereafter the sieving matrix was 
prepared as follows: 9% monomer solution (acrylamide or N, N dimethylacrylamide) with 2% 
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Bis (N,Nʹ-methylenebisacrylamide) and 3 M N,N-dimethylurea was dissolved in 1X TBE 
buffer. A 2% solution of ammonium persulfate (APS) and TEMED 
(tetramethylethylenediamine) was used to initiate polymerisation of the matrix; the tube was 
then vortexed to assist thorough mixing after which a 5 µL volume was quickly added to hole 
(4) until the entire capillary column was filled. Polymerisation can be tracked by monitoring 
the leftover mixture in the eppendorf tube. After the matrix has solidified, 1X TBE buffer is 
added to the anodic reservoir (5) as well as hole (4) to keep the matrix moist. A connection 
should exist between reservoir (5) and hole (4). The DNA sample (synthetic or real) of ±15 
µL is denatured at 95 
0
C for 10 min and then cooled to room temperature on ice before being 
added to the sample reservoir (3). The cathodic reservoir (1) is filled with 1X TBE buffer and 
the microfluidic device is now ready for capillary electrophoresis. CE is carried out by 
applying a voltage of 180 V between the cathodic and anodic reservoirs for 12 min; thereafter 
3 µL samples of DNA are extracted from the recovery outlet (4) at 60 s intervals and collected 
in eppendorf tubes for further analysis.  
 
4.5. Electrokinetic Trapping 
 
Electrokinetic trapping of DNA in this case is the first step in pre-concentrating the dilute 
DNA sample within the micro-fluidic device (Figure 10). This is carried out by applying a 
potential of 1000 V at electrode A in reservoir (2) for 300 s in order to concentrate the DNA 
in front of the PET membrane. At this point electrode A was grounded in reservoir (1) and 
electrode B was left floating. Thereafter, hole (9) is pierced to release the air plug formed 
between the membrane chamber and the matrix within the capillary column. The DNA then 
passes from in front of the membrane to in front of the sieving matrix in the capillary column. 
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4.6. Isotachophoresis 
 
Isotachophoresis is the second step of pre-concentration. A voltage of 250/300 V is applied at 
electrode B in reservoir (6) for 50 s. All the other electrodes are grounded for the ITP process. 
This takes place in front of the sieving matrix, since an ionic gradient exists between the 
slower terminating electrolyte (TE) and the faster leading electrolyte (LE). This causes the 
DNA to stack and concentrate in front of the matrix known as a transient on column pre-
concentration. 
 
After the ITP process a ten second break occurs during which all electrodes are grounded. 
This allows for all the buffers in the device to be exchanged to either LE or 1X TBE buffer. 
This is necessary so that a homogenous buffer system exists to allow for capillary 
electrophoresis to take place.  
 
4.7. Capillary electrophoresis 
 
Capillary electrophoresis is carried out for 120 s by applying a voltage of 180 V at electrode 
B in reservoir 6. After which a volume of 3 µL of DNA is extracted from the recovery outlet 
(7) every 30 or 60 s. These 3 µL fractions are collected in eppendorf tubes and analysed either 
with fluorescence spectroscopy, agarose gel electrophoresis or an Agilent Bioanalyser 
depending on the type of DNA which is used for the experiment.  
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For the optimisation step of the experimental work two types of synthetic DNA was used. A 
42 bp strand of DNA labelled with Rhodamine 6G fluorophores was analysed at a 
concentration of 90 nM. The twelve fractions collected from the micro-fluidic device was 
diluted in 110 µL of Milli Q water each and analysed individually. This DNA was tested 
using fluorescence spectroscopy at an excitation/absorption, λabs = wavelength of 525 nm and 
an emission wavelength, λem = 555 nm. The second type of synthetic DNA used was a 100-
1000 bp DNA ladder stained with ethidium bromide. This DNA consists of 11 fragments: 
100, 150, 200, 300, 400, 500 (2x), 600, 700, 800, 900 and 1000 bp. The experiment was 
carried out in the same way and the 12 fractions collected from the micro-fluidic device were 
stored in eppendorf tubes and tested initially with Agarose gel electrophoresis. A 2% gel was 
prepared with Agarose NA in 1X TBE buffer and stained with GelStar in order to image the 
gel under UV light. The DNA fractions were added to 2 µL of loading buffer and allowed to 
run at voltage = 150 V for 10-15 min. The gel was them imaged under UV light and the size 
separation of the DNA ladder in the micro-fluidic device was determined. Another method of 
DNA ladder analysis is the use of the Agilent Bioanalyser which is also based on gel 
electrophoresis but has a lower and more accurate limit of detection, as low as 5 pg/µL. This 
is a type of lab on a chip technology which has been described in more detail in Chapter 3 
along with the other methodologies mentioned above. 
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CHAPTER 5 
 
5.0. EXPERIMENTAL WORK II 
 
5.1. Process optimisation 
 
The micro-fluidic device consists of many components and processes which occur throughout 
the experiment that require optimisation. This is the bulk of the research and consists of many 
different components and experiments which are described in the sections below. The first set 
of optimisations includes the chemical make-up of the system, such as the capillary column, 
as well as the buffers in the different reservoirs. The original make-up of the capillary column 
matrix was as shown in Table 3: 
Table 3: Original Column Composition 
Function Component Optimised (yes/no) 
Denaturing agent 7 M Urea Yes 
Sieving Matrix 9% Acrylamide Yes 
Buffer system LE buffer Yes 
Crosslinking agent 0.15% Bis No 
Catalyst 0.6% TEMED No 
Radical Initiator 0.12% APS No 
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The above table states the chemical aspects of the experiment which were optimised. The way 
in which this optimisation was carried out is explained below. Note that each optimisation 
experiment was repeated an average of 5 times in order to validate the results obtained. 
 
5.1.1 Denaturing agents 
 
Instead of 7 M urea, various concentrations of N,N-dimethylurea, tetramethylurea, 2-
pyrrolidinone as well as combinations of these were tested as a denaturing agent. This was 
done while all other components were kept constant to have an accurate comparison. 
 
5.1.2. Buffers 
 
Instead of LE buffer as the continuous buffer system during capillary electrophoresis, the 
entire buffer system was replaced with 1X TBE (89 mM tris, 89 mM Boric Acid and 2 mM 
EDTA) buffer while all the other components were kept constant to have an accurate 
comparison. The replacement of the buffer system occurs during the 10 s break which occurs 
after the ITP process at second 351-360.  
 
5.1.3. Sieving Matrix 
 
Instead of 9% acrylamide, various concentrations of poly (N, N-dimethylacrylamide), poly 
(N-hydroxyethylacrylamide), hydroxyethylcellulose, hydroxypropylcellulose, 
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polyvinylpyrrolidone and poly (ethylene oxide) were tested as possible sieving matrices for 
the micro-fluidic device. These individual experiments were all carried out while keeping the 
other parameters constant.  
 
Not only do the chemical aspects of this micro-fluidic device need to be optimised, but also 
the physical processes which occur during the experiment. These include voltage, timing as 
well as temperature. The optimised physical components are as shown in Table 4 below: 
 
Table 4: Original Physical Processes  
Function Component Optimised (yes/no) 
DNA pre-concentration EKT voltage (1000 V) Yes 
DNA pre-concentration ITP voltage (250 V) Yes 
DNA separation CE voltage (180 V) Yes 
Resolution of DNA 
separation 
CE temperature (RT) Yes 
DNA separation Extraction Time (30 s) Yes 
DNA separation 
Capillary column length (1.5 
cm) 
Yes 
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5.1.4. Voltage Changes  
 
The original voltages of the three processes are as shown in the table 4 above. The voltage of 
the isotachophoresis step was increased to 300 V from 250 V. This was done while keeping 
all other parameters of the device constant to monitor the effect on sample loss. The voltage 
of capillary electrophoresis was changed to 140 V, 220 V and 270 V to test the effect of DNA 
resolution with respect to voltage.  
 
5.1.5. Separation Temperature 
 
The original temperature of capillary electrophoresis was kept at room temperature of 25 
0
C. 
This temperature was increased to 40, 50 and 60 
0
C to monitor the effect of temperature on 
the separation and resolution of DNA during capillary electrophoresis while all other 
parameters were kept constant. 
 
5.1.6. Extraction Times 
 
All of the above optimisation steps were carried out using the single sized fragment of 
Rhodamine 6G labelled DNA, and analysed using fluorescence spectroscopy. In order to 
determine the resolution of DNA fragments at different extraction times, the 11 fragments of 
a DNA ladder (100-1000 bp) were used. The extraction times = 30 and 60 s were carried out 
and compared. The separated DNA fractions were collected and analysed using an Agilent 
Bioanalyser.  
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5.1.7. Column Length  
 
The micro-fluidic device originally contains a capillary column of length = 1.5 cm. In an 
attempt to increase resolution or separation of the DNA ladder, a new capillary column chip 
was fabricated with a capillary column of length = 3 cm, double that of the original. The DNA 
ladder was separated in a capillary column with the optimised sieving matrix composition, 
and using a capillary electrophoresis setup at a voltage of 180 V for time = 12 min. The 
separated DNA ladder was then collected in 12 fractions at every 30 or 60 s interval; collected 
in eppendorf tubes and analysed using an Agilent Bioanalyser.  
 
5.2. Application to real samples 
 
Once the entire protocol was optimised, both the chemical and physical aspects, the micro-
fluidic device were used to concentrate and separate a maternal plasma sample from a 
pregnant mother carrying a male foetus. The final experimental protocol can be outlined in 
table 5 below: 
  
  
 
 
73 
 
Table 5: Optimised Protocol 
Component Function Final Value 
Sieving Matrix Acrylamide or pDMA 9% 
Denaturing Agent N, N-dimethylurea 3 M 
EKT and ITP buffer LE and TE buffer  
CE Buffer TBE 1X 
ITP Pre-concentration of DNA 300 V 
CE DNA separation 180 V 
CE Temperature DNA resolution RT (25 
0
C) 
DNA extraction DNA separation 60 s 
Column Length DNA separation 3 cm 
 
The optimised protocol was then applied to ten real samples of DNA which contained 
unknown amounts of cell free foetal DNA. The 12-14 DNA fractions were collected in 
eppendorf tubes and analysed using Real Time PCR. The protocol is as described below: 
 
5.2.1 Real Time PCR Protocol 
 
Real Time PCR was used as a method to distinguish maternal DNA from foetal DNA in the 
maternal plasma samples. This was done by amplifying two genes: the CCR5 gene which is a 
general gene present in the genome of both males and females; and the DYS14 gene which is 
male specific. The amplification of the latter will indicate the presence of cell free foetal 
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DNA. The RT-PCR protocol involved the construction of a calibration plot to quantify the 
amount of DNA in each unknown DNA fraction. This was done by preparing increasing 
concentrations of male genomic DNA to plot a standard curve at concentrations of 25.4 
ng/μL, 2.54 ng/μL, 0.254 ng/μL and 25.4 pg/μL. A positive control was also included in the 
protocol as male genomic DNA at a concentration of 175 ng/μL. A negative control in the 
protocol consisted of female genomic DNA which was used at a concentration of 212 ng/μL. 
A volume of 1 µL of the unknown fractions, the standard curve aliquots as well as the positive 
and negative controls were added to the wells of a 384 micro titre plate along with 4 µL of 
master mix for the RT-PCR amplification.  
 
The master mix for the male specific DYS14 contained 2.5 μL TaqMan PCR mix, 0.3 μL 
DYS14 primer mix, 0.1 μL DYS14 probe labelled with FAM and 1.1 μL nuclease free water. 
The master mix for CCR5 contained 2.5 μL TaqMan PCR mix, 0.2 μL CCR5 primer mix, 0.1 
μL CCR5 probe labelled with FAM and 1.2 μL nuclease free water. In the case of the positive 
and negative controls, as well as the standard curve master mix, the nuclease free water 
contained 20% 1X TBE buffer. The plate was then sealed with optical film and spun at 1000 
rpm for 1 min. The real time PCR protocol was carried out by denaturing DNA for 10 min at 
95 
0
C and then annealing for 2 min at 50 
0
C. Thereafter amplification was carried out by 45 
cycles of 15 s at 95 
0
C and 1 min at 56 
0
C. 
 
A diagram that represents the layout of the 384 well micro-titre plate is as shown in Table 6:  
  
 
 
75 
 
Table 6: Representation of PCR micro-titre plate layout 
24
     
B
la
n
k
_D
Y
S 
B
la
n
k
_C
C
R
5
          
23
 
    
B
la
n
k
_D
Y
S 
B
la
n
k
_C
C
R
5
          
22
     
B
la
n
k
_D
Y
S 
B
la
n
k
_C
C
R
5
          
21
     
S4
_D Y
S 
S4
_C
C
R
5
 
         
20
 
fe
m
g
en
 
C
C
R
5 
m
al
e
ge
n
 
C
C
R
5   
S4
_D Y
S 
S4
_C
C
R
5
 
         
19
 
fe
m
g
en
 
C
C
R
5 
m
al
e
ge
n
 
C
C
R
5   
S4
_D Y
S 
S4
_C
C
R
5
 
         
18
 
Fe
m
g
en
C
C
R
5
 
m
al
e
ge
n
 
C
C
R
5   
S3
_D Y
S 
S3
_C
C
R
5
 
         
17
 
    
S3
_D Y
S 
S3
_C
C
R
5
 
         
16
 
fe
m
g
en
D
Y
S 
m
a
le
g
en
D
Y
S   
S2
_
D
Y
S 
S2
_C
C
R
5          
15
 
fe
m
g
en
D
Y
S 
m
a
le
g
en
D
Y
S   
S2
_D Y
S 
S2
_C
C
R
5
 
         
14
 
fe
m
g
en
D
Y
S 
m
a
le
g
en
D
Y
S   
S1
_D Y
S 
S1
_C
C
R
5
 
         
13
     
S1
_D Y
S 
S1
_C
C
R
5
 
         
12
 
               
11
                
10
 
0B
_C
C
R
5
 
1B
_
 
C
C
R
5
 
2B
_
 
C
C
R
5
 
3B
_
 
C
C
R
5
 
4B
_
 
C
C
R
5
 
5B
_
 
C
C
R
5
 
6B
_
 
C
C
R
5
 
7B
_
 
C
C
R
5
 
8B
_
 
C
C
R
5
 
9B
_
 
C
C
R
5
 
10
B
_
 
C
C
R
5
 
11
B
_
 
C
C
R
5
 
12
B
_
 
C
C
R
5
 
13
B
_
 
C
C
R
5
 
14
B
_
 
C
C
R
5
 
9                
8                
7 
0A
_C
C
R
5
 
1A
_ 
C
C
R
5
 
2A
_ 
C
C
R
5
 
3A
_ 
C
C
R
5
 
4A
_ 
C
C
R
5
 
5A
_ 
C
C
R
5
 
6A
_
 
C
C
R
5
 
7A
_ 
C
C
R
5
 
8A
_ 
C
C
R
5
 
9A
_ 
C
C
R
5
 
10
A
_ 
C
C
R
5
 
11
A
_ 
C
C
R
5
 
12
A
_ 
C
C
R
5
 
13
A
_ 
C
C
R
5
 
14
A
_ 
C
C
R
5
 
6                
5 
0B
_
D
Y
S 
1B
_
D
Y
S 
2B
_
D
Y
S 
3B
_
D
Y
S 
4B
_
D
Y
S 
5B
_
D
Y
S 
6B
_
D
Y
S 
7B
_
D
Y
S 
8B
_
D
Y
S 
9B
_
D
Y
S 
10
B
_
D
Y
S 
11
B
_
D
Y
S 
12
B
_
D
Y
S 
13
B
_
D
Y
S 
14
B
_
D
Y
S 
4 
0B
_
D
Y
S 
1B
_
D
Y
S 
2B
_
D
Y
S 
3B
_
D
Y
S 
4B
_
D
Y
S 
5B
_
D
Y
S 
6B
_
D
Y
S 
7B
_
D
Y
S 
8B
_
D
Y
S 
9B
_
D
Y
S 
10
B
_
D
Y
S 
11
B
_
D
Y
S 
12
B
_
D
Y
S 
13
B
_
D
Y
S 
14
B
_
D
Y
S 
3                
2 
0A
_
D
Y
S 
1A
_
D
Y
S 
2A
_
D
Y
S 
3A
_
D
Y
S 
4A
_
D
Y
S 
5A
_
D
Y
S 
6A
_
D
Y
S 
7A
_
D
Y
S 
8A
_
D
Y
S 
9A
_
D
Y
S 
10
A
_
D
Y
S 
11
A
_
D
Y
S 
12
A
_
D
Y
S 
13
A
_
D
Y
S 
14
A
_
D
Y
S 
1 
0A
_
D
Y
S 
1A
_
D
Y
S 
2A
_
D
Y
S 
3A
_
D
Y
S 
4A
_
D
Y
S 
5A
_
D
Y
S 
6A
_
D
Y
S 
7A
_
D
Y
S 
8A
_
D
Y
S 
9A
_
D
Y
S 
10
A
_
D
Y
S 
11
A
_
D
Y
S 
12
A
_
D
Y
S 
13
A
_
D
Y
S 
14
A
_
D
Y
S 
 A
 
B
 
C
 
D
 
E F G
 
H
 I J K
 L M
 
N
 
O
 
  
 
 
76 
 
Key for Table 5: 
A/B    Repetitions of the same experimental protocol 
n = 1, 2, 3 etc.   Fraction number extracted from the chip 
DYS    Male specific gene to be amplified 
CCR5    General gene to be amplified 
S1-4 Standard concentrations of male genomic DNA to be used as a 
calibration curve 
Femgen Female genomic DNA (positive/negative control) 
Malegen Male genomic DNA (positive control for DYS) 
Blank Sample with no DNA present, only nuclease free water 
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CHAPTER 6 
 
6.0 RESULTS AND DISCUSSION 
 
6.1. Optimisation 
 
The optimisation of the micro-fluidic device was carried out by concentrating and separating 
synthetic DNA. Various parameters and processes were changed and the effect on the DNA 
separation and resolution was monitored using fluorescence spectroscopy, Agilent 
Bioanalyser and Agarose gel electrophoresis. The results of each optimisation step are 
discussed below: 
 
6.1.1 Denaturing agents 
 
DNA size separation requires both accuracy and reproducibility, but what is very important in 
this case, is the resolution or separation of these DNA fragments. This is because the ideal 
goal is to use this device to separate cell free foetal DNA from maternal DNA, by taking 
advantage of the size of the respective molecules. One of the components of this device which 
could greatly improve the resolution of DNA fragments is the addition of a denaturing agent 
to the capillary column matrix in which the DNA is separated. One of the most commonly 
used denaturing agents in electrophoresis is urea [63]. It has been shown to greatly improve 
the resolution of DNA fragments at high concentrations of about 7 M.  
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Urea denatures DNA by unfolding the secondary structure of the molecule. This forces the 
molecule to unfold as well as the internal hydrogen bonds of the double strand to break and 
produce single stranded DNA. The primary driving force of this type of denaturation is the 
strong interaction between urea and the bases of the DNA which have a large surface area 
[113]. A proposed representation of the denaturing mechanism can be represented in Scheme 
5 below: 
 
Scheme 5: Proposed mechanism of DNA denaturing by urea 
 
In this case a single sized 42 bp fragment of Rhodamine 6G labelled DNA was added to the 
micro-fluidic device at a concentration of 90 nM. The fluorescence intensity of this initial 
DNA sample was measured using fluorescence spectroscopy and compared to each of the 12 
fractions extracted from the micro-fluidic device. A representation of the experiment with 7 
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M urea as a denaturing agent is shown below with fluorescence intensity as a function of the 
fraction number in Figure 13 below: 
  
Figure 13: Separation of DNA in 9% acrylamide with 7 M urea as denaturing agent 
 
The recovery fraction is a 10-15 µL aliquot of the liquid leftover in the sample chamber which 
is analysed to determine sample loss during the experimental process. Since the DNA is 
present only in a single sized fragment (42 bp), we expect that the DNA should exit the 
micro-fluidic device in a single fraction. As seen in Figure 13, the DNA does not exit in a 
single fraction but rather trails in all of the fractions exiting the chip. In the optimisation 
process one could view resolution as the ability of the single fragment to exit the chip all at 
the same instance. This shows that urea is a decent denaturing agent but improvements need 
to be made. The denaturing ability of urea has been shown to increase with an increase in 
alkyl substitution [59]. Therefore, together with urea, N,N-dimethylurea and tetramethylurea 
have been tested as a denaturant at various concentrations in the sieving matrix of the 
capillary column. The best results obtained from all the concentrations of denaturing agent 
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tested, was found to be 3 M N,N-dimethylurea. The resolution of the DNA exiting the chip 
with various concentrations of N,N-dimethylurea is shown below in Figure 14: 
  
Figure 14: Separation of DNA in 9% acrylamide with various concentrations of N, N-
dimethylurea 
 
In this case one can clearly see the excellent resolution of the DNA fragment which the 3 M 
N,N-dimethylurea produces. In this case the DNA fragment exits the column or micro-fluidic 
device in a single fraction very early in the process. This is the ideal situation since small 
fragments of DNA should exit the device both early and in a single fraction.  
 
Along with urea derivatives, organic solvents have also been found to improve the resolution 
of DNA in electrophoresis by acting as a denaturing agent. These solvents include ethanol, 
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methanol and pyrrolidinone. Pyrrolidinone was tested as a possible denaturant on its own as 
well as in combination with 3 M N,N-dimethylurea. However, it did not improve the 
resolution of the DNA much greater than compared to N,N-dimethylurea on its own and was 
thus not considered as a viable addition to the sieving matrix. From now on 3 M N,N-
dimethylurea will be used as the denaturing agent in all further experiments.       
 
6.1.2. Sieving Matrix 
 
Acrylamide is one of the most widely used gels for electrophoresis of both proteins and DNA. 
In attempts to check both the versatility of the micro-fluidic device as well as other options 
for improving the resolution of DNA, other sieving matrices were tested. The most viable 
options in this case would seem to be derivatives of acrylamide such as poly(N,N-
dimethylacrylamide) and poly(N-hydroxyethylacrylamide) as well as linear poly(acrylamide) 
(LPA). LPA has been shown to give excellent resolution of DNA fragments in terms of DNA 
sequencing [56] and is very widely used. However, LPA was unsuitable for the micro-fluidic 
device because of its high viscosity and thus difficulty in adding the matrix to the small 
capillary column. Since the micro-fluidic device will be dealing with biological samples such 
as DNA, an aqueous system is required. This requires polymers that are easily dissolvable in 
aqueous media. Other polymers were also considered; these include cellulose based polymers 
such as hydroxyethylcellulose and hydroxypropylcellulose. Cellulose based matrices are 
found to have a wide application in electrophoresis [58] as well as other DNA and protein 
separation. Polyvinylpyrrolidone has also been found to be useful as an additive to polymer 
matrices for DNA separation. Low viscosity, water soluble polymers such as poly(ethylene 
oxide) has also shown to have good resolution of DNA in capillary columns [114]. The 
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polymerisation of the matrix in this case has to be controllable, as well as easy for this type of 
micro-fluidic device. Thus out of all the polymers mentioned and tested, acrylamide and its 
derivatives were found to be the most viable options. Below is an image (Figure 15) 
representing the optimisation of the sieving matrix by comparing the resolution of a 42 bp 
DNA fragment labelled with Rhodamine 6G. 
  
Figure 15: Acrylamide and pDMA 
 
As can be seen in the Figure 15 above, both acrylamide as well as pDMA give excellent 
resolution of the single 42 bp DNA fragment. This is due to the fact that the DNA fragment 
exits the capillary column with the majority of DNA in a single fraction. However, tiny 
amounts of DNA are present on the fractions surrounding the major, which motivates us to 
improve DNA resolution even further. 
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6.1.3. Buffers  
 
In all cases thus far, the buffers used were the conventional LE and TE buffer for EKT and 
ITP and only LE buffer for CE. This is also another aspect of the system which affects the 
resolution of the DNA fragments within the capillary matrix. 1X TBE buffer is widely used in 
gel electrophoresis and has been shown to have a better resolution ability compared to tris 
buffers which do not contain borate ions [115]. In the first two pre-concentration steps of the 
experimental protocol, an ion gradient has to exist for the phenomenon to occur. Thus a 
homogenous buffer system can only be used during CE. 1X TBE buffer was chosen to be 
used only during the separation process and replaced both TE and LE buffers in all the 
reservoirs for this step. 1X TBE buffer was found to greatly improve the resolution of the 
DNA fragment in this case, which can be represented by comparing a pDMA matrix in both 
LE and 1X TBE buffer for CE in Figure 16 below: 
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Figure 16: pDMA resolution in LE and TBE buffer for CE 
 
pDMA as a sieving matrix in LE buffer showed a much worse resolution compared to 1X 
TBE buffer in this case. With LE buffer the DNA exits the column in all fractions extracted 
from the chip, whereas with 1X TBE buffer, the majority of the DNA exits in a single 
fraction. From now on, all the optimised conditions are being used in the experimental 
protocol, which is 9% acrylamide/pDMA, 3 M N,N-dimethylurea in 1X TBE buffer. Now 
that the chemical composition of the sieving matrix and buffer system is optimised, physical 
processes occurring within the micro-fluidic device need to be optimised as well. 
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6.1.4. Separation Temperature 
 
Many factors influence the separation of DNA, one which is important in most DNA analysis 
procedures, is the level of DNA denaturation. This can either be carried out using chemical 
denaturing agents, but also in the form of heat. DNA is known to denature or melt at 
temperatures higher than 90 
0
C by breaking the weak hydrogen bonds which hold double 
stranded DNA together. A denaturation temperature of 95 
0
C is largely used in the initial step 
of a PCR protocol for DNA amplification. Incorporating thermal denaturation of DNA into 
the capillary electrophoresis step requires a slightly lower temperature in order to maintain the 
structure of the gel. A temperature = 60 
0
C was found to be optimal for capillary 
electrophoresis [63] by increasing DNA resolution. However, these are usually applied to 
much longer and more robust capillary columns in sequencing machines. For a micro-fluidic 
device on this scale, gas formation becomes an issue within the micro-channels which 
interferes with the various processes within the device. Temperatures ranging from 40 - 60 
0
C 
were tested during capillary electrophoresis within the micro-fluidic device. The result of the 
applied temperature during capillary electrophoresis however was not found to greatly 
increase DNA resolution. Thus in this particular case it was found to be an unnecessary 
application or usage of energy.  
 
6.1.5. Voltage Changes 
 
The effect of the applied voltage of each of the steps is a vital part in controlling the migration 
of DNA within the device. Electrokinetic trapping has a relatively high voltage of 1000 V. 
However, this process has sufficiently concentrated the DNA during the optimisation process. 
  
 
 
86 
 
The second pre-concentration step of isotachophoresis has been shown to result in sample loss 
by inefficiently transferring the DNA from the sample chamber to stack in front of the column 
as shown in the scheme 6 below: 
 
 
Scheme 6: Inefficient ITP process 
 
A thin balance exists between the buffer gradient required for ITP and the time taken for the 
DNA to enter the sieving matrix. Thus it was not seen as a good idea to lengthen the ITP 
process any more than the original time = 50 s. Lengthening the time of ITP would increase 
the chances of the DNA entering the column instead of concentrating in front of it. Instead the 
voltage of this step was increased from 250 V to 300 V. A 50 V increment was chosen in 
order to sufficiently monitor a change within the process. Lower increments do not show a 
significant change in the ITP process. The migration of the 42 bp DNA fragment in this 
column is represented in Figure 17, by comparing the amount of DNA with an ITP voltage = 
250 V and 300 V respectively. 
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Figure 17: The effect of an increased ITP voltage on sample loss 
 
In both these cases the same amount of DNA was inserted into the micro-fluidic device. 
However, from these results it is clear that a lower ITP voltage results in a lower amount of 
DNA which exits the micro-fluidic device. In this case there is a 30 % increase in the sample 
extraction with an increase of ITP voltage to 300 V. The increase of 50 V sufficiently proved 
that increasing the voltage decreased sample loss during ITP in this case. Therefore in all 
further experiments the ITP voltage was kept at 300 V. The ITP voltage can be adjusted 
further in future experiments with various concentrations of DNA, synthetic or real. 
 
Now that the DNA loss is minimised within the device, we can try and have optimal 
separation and also resolution of the DNA fragments. This can be done using the same 
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rationale as before and thus changing the voltage of capillary electrophoresis. The original 
value of voltage = 180 V showed good resolution with the acrylamide matrix, however with 
the pDMA matrix the migration of DNA was slightly slower. In attempts to increase the speed 
with which the DNA migrates through the capillary column, higher voltages were tested. 
Capillary electrophoresis voltages of 220 V and 270 V with the pDMA matrix were tested i.e. 
at increments of 40 V to ensure an accurate comparison and differentiation. These were found 
to increase the speed with which the DNA migrates through the column, but have a negative 
effect on the resolution of the DNA fragment. Previously it was possible to extract the 42 bp 
DNA fragment in a single fraction, whereas with the higher voltages the DNA was extracted 
in about 2 fractions. Thus the voltage = 180 V for the pDMA matrix was retained. 
 
In an attempt to capture the entire DNA sample from the acrylamide matrix in a single 
fraction, a lower voltage of capillary electrophoresis was also tested i.e. at 40 V lower than 
the original: voltage = 140 V. One would think that the DNA would migrate slower through 
the matrix and thereby have a better resolution by allowing a longer time for the DNA to 
separate. However, the migration was much slower and resulted in very bad resolution. In this 
case one can assume that the applied voltage was not sufficient enough to promote efficient 
capillary electrophoresis. Therefore in all cases from now on, a general voltage of 180 V was 
used during capillary electrophoresis. The next parameter which might assist in the resolution 
of DNA might be the timing at which the DNA is extracted from the micro-fluidic device.  
 
 
  
 
 
89 
 
6.1.6. Extraction Times 
 
To truly compare the effect of the timing of extraction on DNA resolution and size separation, 
more than one fragment of DNA is required. In this case a 100-1000 bp synthetic DNA ladder 
was used. The optimised protocol using a 9% acrylamide matrix, 3 M N,N-dimethylurea in 
1X TBE buffer for CE was used to pre-concentrate and separate this DNA ladder in the 
micro-fluidic device. Here extraction times = 30 and 60 s were compared. This type of DNA 
was initially analysed using Agarose gel electrophoresis. In cases where the concentrations of 
the fragments were too low for visualisation on an agarose gel, an Agilent Bioanalyser was 
used. This instrument is based on the same theory as gel electrophoresis but has a better limit 
of detection. The Agilent Bioanalyser electrophoresis gel results representing the 30 s 
extraction time is as shown in Figure 18 below: 
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Ladder 1 2 3 4 5 6 7 8 9 10 11 12 
 
Figure 18: (a) Gel image of DNA ladder separation with 30 s extraction (b) 
Representation of DNA concentration in each fraction extraction at 30 s intervals 
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In this case, the EKT process is carried out for 300 s, ITP for 50 s and CE for 120 s. 
Thereafter a 3 µL sample is extracted from the micro-fluidic device every 30 s. The graph 
above represents the gel image in terms of the concentration of each DNA fragment in the 
ladder which is present in each fraction extracted from the micro-fluidic device. As we can 
see, the smaller sized fragments exit the micro-fluidic device earlier in the protocol compared 
to the larger fragments. This proves that the experiment works in terms of separating DNA 
according to size. However, the resolution of this experiment can be improved further. 
Currently, it is possible to separate the 100 bp fragment in fraction 6. However fraction 7 
contains fragments of 100 bp and 150 bp together. These results are good but the 
concentrations of each of these fragments are still low. We went on to test the separation of 
the DNA ladder with 60 s extractions. The results are as shown in Figure 19 below: 
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Ladder 1 2 3 4 5 6 7 8 9 10 11 12 
 
 
Figure 19: (a) Gel image of DNA ladder separation with 60 s extraction (b) 
Representation of DNA concentration in each fraction extraction at 60 s intervals 
 
As we can see from these results, the resolution of DNA is basically the same as with the 30 s 
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the recovery outlet. Here the same trend occurs, with the 100 bp fragment being isolated in an 
earlier fraction, and then present along with the 150 bp fragment in the next fraction. We thus 
concluded that the time = 60 s for extraction was better. The longer extraction time did not 
interfere with the resolution and also allowed the DNA to collect in the recovery outlet. This 
is an added benefit when dealing with real DNA samples, since more DNA can be used for 
further analysis. We went on to test further parameters which could possibly affect the 
resolution/separation of the DNA ladder within the microfluidic device.  
 
6.1.7. Column Length 
 
So far the device contained a capillary column which was fixed at 15 mm in length. It is 
proposed that an increase in this capillary column length could in fact increase the resolution 
of the DNA fragments by allowing more time and space in which the fragments could 
separate. Previous work has shown that this theory is valid i.e. an increase in column length 
has increased resolution of DNA fragments [116]. A new micro-fluidic device was fabricated 
which contained only a capillary column with double the length as that of the previous one. 
This was the maximum length of column achievable on the PMMA substrate using the CO2 
laser. Longer columns could be achieved if they were produced in different designs instead of 
just a straight line. However, this design was chosen so as to achieve a maximum consistency 
between the parameters and to allow for accurate comparisons. In this case, the DNA ladder 
concentration added to the sample reservoir was optimised in such a way that the experiment 
is comparable to those carried out previously. Capillary electrophoresis in a 9% pDMA matrix 
was carried out and fractions of DNA were extracted at time = 60 s intervals from the 
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recovery outlet of the micro-fluidic device. The results of the Agilent Bioanalyser analysis are 
as shown below in Figure 20: 
Ladder 1 2 3 4 5 6 7 8 9 10 11 12 
 
 
Figure 20: (a) Gel image of DNA ladder separation in 30 mm capillary column (b) 
Representation of DNA concentration in each fraction extracted from capillary column 
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As we can see, a lot more DNA is present within the protocol timing. This is much more 
favourable compared to previous experiments. Not only is there more DNA present in each 
fraction, the separation of the individually sized DNA fragments are greatly improved. 
Although each fragment is not isolated completely in a single fraction, each size has a 
maximum concentration (Cmax) in one of them as shown in Table 7 below: 
Table 7: Relative maximum concentrations of DNA fragments exiting the microfluidic 
device 
Fragment Cmax Fraction 
100 bp 0.23 ng/µL 4 
150 bp 0.26 ng/µL 4 
200 bp 0.36 ng/µL 5 
300 bp 0.36 ng/µL 10 
400 bp 0.47 ng/µL 11 
500 bp 0.37 ng/µL 11 
 
Here we can see that it is possible to collect and isolate larger concentrations of the smaller 
fragments of DNA. All fragments that are smaller than 300 bp can be completely isolated 
from the rest in the first 6 fractions extracted from the device. This is a benefit if the micro-
fluidic device will be used as a method of separating cell free foetal DNA from a maternal 
plasma sample. This is because cffDNA exists in the mother’s blood stream in fragments less 
than 300 bp in length. Thus, in future the device will be re-designed in order to incorporate 
capillary columns that are 30 mm or even longer in order to separate DNA fragments with 
excellent resolution. Although these complete devices were not manufactured for use in this 
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work, the theory that a longer capillary column gives better resolution of DNA, has been 
successfully proven. 
 
6.2. Application to Real Samples 
 
Now that all the parameters within the device have been successfully optimised and 
incorporated into a final experiment, it will be applied to real sample analysis. As stated 
before, these samples were obtained from women pregnant with male foetuses. DNA was 
isolated from the blood of the mother and used in these experiments. The protocol can be 
summarised again as follows: 
 
The matrix which was inserted into the capillary column contained either 9% 
acrylamide/pDMA as a sieving matrix, 3 M N,N-dimethylurea as a denaturing agent. Once 
the sieving matrix was fixed, 10X 80 µL real DNA samples were analysed separately, they 
were each added to the sample reservoir through hole 5 of the device. Buffers used for EKT 
and ITP processes were the conventional LE and TE buffers. All buffers were replaced with 
1X TBE buffer for capillary electrophoresis. EKT voltage remained at 1000 V for 300 s. ITP 
was carried out at voltage = 300 V for 50 s and CE at voltage = 180 V. Extraction of DNA 
from the device was carried out at 60 s intervals starting at minute 8 until 14 fractions were 
collected. Each of these fractions were analysed using Real Time PCR. The protocol involved 
the amplification of two genes: DYS14 which is male specific and CCR5 which is present in 
both males and females. In this way it is made possible to distinguish whether each fraction 
contains male or female DNA. If the DYS14 gene is amplified, the DNA belongs to the foetus 
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and is considered cell free foetal DNA. If the CCR5 gene is amplified and NOT the DYS14 
gene, we can assume that this DNA belongs to the mother. Keeping in mind that cell free 
foetal DNA is usually less than 300 bp in length, this DNA should theoretically be present in 
the initial samples extracted from the chip, since smaller fragments of DNA has been proven 
to move through the matrix quicker. Therefore, the larger maternal DNA should be present in 
the later fractions, since this DNA is usually more than 500 bp in length and thus move more 
slowly through the sieving matrix. For the purpose of clarity, only one RT-PCR experiment is 
represented here.  
 
As proof that the RT-PCR protocol is successful, the standard curve of each gene i.e. DYS14 
and CCR5 is shown below. These standard curves also indicate the presence of the positive 
controls, which is male genomic DNA for the DYS14 gene and female genomic DNA for the 
CCR5 gene. It also shows that the negative controls were not amplified i.e. female genomic 
DNA with DYS14 amplification. The protocol representing the amplification of the CCR5 
gene is shown in Figure 21 below: 
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Figure 21: Standard Curve representation of CCR5 amplification 
 
According to The Cyprus Institute of Neurology and Genetics (CING), who provided the RT-
PCR protocol, the slope of the standard curve has to be in the range of -3.5 to -4.5. Therefore 
we can conclude that this experiment was successful since the slope is -4.4 as well as the fact 
that the standards were reproducible. The positive controls for CCR5 gene contained female 
genomic DNA at a concentration of 212 ng/µL. According to the RT-PCR results, the positive 
controls contained an average of 191 ng/µL with a standard deviation of 4,38 ng/µL. A graph 
which represents the amplification of these positive control samples are as shown in Figure 22 
below.  
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 Figure 22: Amplification of CCR5 gene in positive control samples 
 
This shows that the protocol gives a result that is in the range of ±21 ng/µL accuracy for the 
positive controls.  
The theoretical initial concentration of cell free foetal DNA was calculated to be 4.46 pg/µL 
since this is the amount of DNA amplified by the DYS14 gene. One can conclude that the 
total amount of DNA that the initial samples contained would be those amplified by the 
CCR5 gene. This amount was calculated to be 319 pg/µL, making the cell free foetal DNA 
approximately 2% of the total maternal plasma DNA sample in this case. The graph which 
represents the DYS14 amplification is as shown in Figure 23: 
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Figure 23 Standard Curve representation of DYS14 amplification 
 
In the standard curve representing the DYS14 gene protocol, the slope is -3.638. This is 
within the required range of -3.5 to -4.5 and can be considered confirmation that the 
experiment was successful for the DYS14 amplification. The positive controls contain a high 
concentration of male genomic DNA (175 ng/µL) and is thus at the far right of the graph 
which show a high quantity of DNA and also a low Ct value. The Ct values can be defined as 
the number of cycles that are required for the fluorescent signal to cross the threshold or 
background signal and are inversely proportional to the concentration of the target DNA. This 
means that a lower Ct value indicates a higher concentration of target DNA and that this DNA 
had to undergo less amplification cycles before it was detectable by the equipment. The 
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results of the real time PCR can also be represented by a graph which shows the amplification 
of each gene by plotting the Ct value versus fraction number in Figure 24 below: 
 
 
Figure 24: Representation of the presence of cell free foetal DNA in initial samples 
extracted from micro-fluidic device 
 
The initial DNA samples were also represented on the standard curve plot, with an average 
concentration of 4.46 pg/µL as stated previously. The second fraction which exited the chip 
shows amplification of the DYS14 gene, with a concentration of 0.04 pg/µL and a Ct value of 
43.99. The 10
th
 and 12
th
 fraction exiting the chip contained the CCR5 gene since this gene 
was amplified. The fact that only CCR5 was amplified in these fractions, as well as the fact 
that they occur so late in the process, confirms that this DNA belongs to the mother. This is 
because maternal DNA is larger in size compared to foetal and obviously does not contain the 
DYS14 gene. The concentration of DNA in fraction 10 was calculated to be 7.14 pg/µL of 
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DNA with a Ct value of 43.2. The DNA present in fraction 12 had a concentration of 317,24 
pg/µL and a Ct value of 35.9.  
Since the micro-fluidic device separated DNA according to size, we can assume that this 
DNA fragments were in the range of 100-1000 bp. This is because the device was optimised 
using synthetic DNA in this range. During the protocol only fragments up to 500 bp were 
collected within the time frame shown here. Fragments that are greater in size than 500 bp can 
possibly be collected if the protocol time was extended. Maternal DNA exists in larger 
fragments than 500 bp and thus not all of the DNA that exists in the sample might be 
represented in the graph. Leftover DNA will probably still be present either in the sample 
chamber or capillary column of the micro-fluidic device.  
 
The fact that this concentration is far less concentrated than the initial sample shows that one 
of the pre-concentration steps within the micro-fluidic device had failed. We are positive that 
all processes occurred in the optimisation protocol, and can thus conclude that problems 
occurred because of the nature of the real samples and its effect on the EKT step. It was noted 
that the current flow during EKT when dealing with real samples was considerably lower 
compared to the synthetic DNA. We can thus attribute the decrease in DNA concentrations 
present in the fractions to an inefficient EKT process. Although the experimental protocol was 
carried out on all ten real samples, the results of only one of them is shown here. This is due 
to the fact that there were several issues which arose when dealing with real sample analysis 
which resulted in irreproducible outcomes. The trend of results however should remain the 
same with all ten real samples. This problem will have to be resolved in future with a more 
extensive study concerning real sample analysis with the micro-fluidic device.  
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Nonetheless, we can conclude that the micro-fluidic device successfully isolated cell free 
foetal DNA from at least one maternal blood sample, since the DYS14 gene was amplified in 
an initial fraction, separate from the maternal DNA which was present in later fractions.  
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CHAPTER 7 
 
7.0. CONCLUSION 
 
A non-invasive prenatal test was proposed by taking advantage of the presence of cell free 
foetal DNA in the maternal blood stream. In this work, a microfluidic device was designed 
and optimised for the separation of cell free foetal DNA from maternal blood to allow for 
further genetic testing. Cell free foetal DNA is characteristically short in length, i.e. less than 
300 bp, and can thus be separated by size from larger DNA. Here it is carried out by using 
advances in micro-fluidics and the development of a device capable of separating DNA 
according to size. The micro-fluidic device used three processes in order to isolate and 
separate cell free foetal DNA. All the components and processes occurring within the device 
were optimised and tested using synthetic DNA. The optimised protocol used a 9% 
acrylamide/pDMA sieving matrix with 3 M N,N-dimethylurea as a denaturing agent in which 
to separate the DNA. For electrophoresis a homogenous buffer system of 1X TBE was found 
to improve DNA separation and thus resolution at a voltage of 180 V and extraction time of 
60 s. The isotachophoresis worked best at a voltage of 300 V and resulted in 30% reduction in 
sample loss. The optimised protocol was then applied to real sample analysis obtained from 
women pregnant with male foetuses. The micro-fluidic device successfully isolated cell free 
foetal DNA from a maternal plasma samples. This was proven to be accurate using real time 
PCR analysis and amplification of a sex related gene.  
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7.1 Recommendations 
 
In future, I would recommend that the device incorporate longer capillary columns in which 
to separate the DNA in order to have a better resolution and size separation. Also the micro-
fluidic device should be altered and further optimised in order to appropriately analyse real 
samples. The design of the device can also be altered in order to enhance each process 
occurring. Further studies can be done to test whether the device can be re-used for more than 
one experiment.   
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